SVM-light Version V5.01-TK-1.5
5 # kernel type
3 # kernel parameter -d 
1 # kernel parameter -g 
1 # kernel parameter -s 
1 # kernel parameter -r 
empty# kernel parameter -u 
0.4 # kernel parameter -L 
1 # kernel parameter -T 
S # kernel parameter -C 
1 # kernel parameter -F 
0 # kernel parameter -S 
0.400000 # kernel parameter -M 
3 # kernel parameter -N 
S # kernel parameter -V 
S # kernel parameter -W 
0 # kernel parameter -U 
5686 # highest feature index 
296 # number of training documents 
165 # number of support vectors plus 1 
1.0007674 # threshold b, each following line is a SV (starting with alpha*y)
-0.1684176346927728218361153267324  |BT| (S (NP (NP (NP (JJ (Epidermal))(NN (growth))(NN (factor))(NN (receptor)))(PRN (-LRB- (-LRB-))(NP (NN (EGFR)))(-RRB- (-RRB-))))(NN (tyrosine))(NN (kinase))(NN (inhibitor))(NN (erlotinib)))(VP (VBP (show))(SBAR (S (NP (JJ (potent))(NP (NP (NN (antitumor))(NN (activity))(JJ (non-small-cell))(NN (lung))(NN (cancer)))(PRN (-LRB- (-LRB-))(NP (NN (NSCLC)))(-RRB- (-RRB-))))(NN (cell))(NN (line)))(VP (VBD (approved))(NP (NNP (Food))(NNP (Drug))(NNP (Administration))(JJ (second))(JJ (third))(NN (line))(NN (treatment))(NN (NSCLC)))))))) |ET|  |BS| 52:E02 64:D08.811.913.696.620.682.725.400.009.300 110:C04.588.894.797.520.109.220.249 113:C04.697.650 633:I01.409.418.750.600.650.760 634:D12.125.072.050.875  |ES| 10:1 14:1 18:1 19:1 22:1 94:1 102:1 185:1 186:1 187:1 264:1 327:1 328:1 329:1 380:1 399:1 429:1 470:1 546:1 2244:1 2340:1 2341:1 2342:1 2343:1 2344:1 2345:1 2346:1 2347:1 2348:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (ADVP (RB (Additionally)))(, (,))(NP (NP (NP (NN (transcription))(NN (factor))(JJ (early))(NN (growth))(NN (response-1)))(PRN (-LRB- (-LRB-))(NP (NN (Egr-1)))(-RRB- (-RRB-))))(NN (gene))(ADJP (RB (transcriptionally))(VBN (activated)))(NN (level))(NP (NP (JJ (non-steroidal))(JJ (anti-inflammatory))(NN (drug)))(PRN (-LRB- (-LRB-))(NP (NN (NSAID)))(-RRB- (-RRB-)))))(: (-))(NP (NP (NP (VBN (activated))(NN (gene-1)))(PRN (-LRB- (-LRB-))(NP (NN (NAG-1)))(-RRB- (-RRB-))))(NN (protein)))(ADVP (RB (also)))(VP (VBD (elevated))(NP (JJ (PTX-2-treated))(NN (Hep3B))(NN (cell))))) |ET|  |BS| 6:G05.360.340.024.340 7:D12.776 41:A11 52:E02 580:D12.776.260.158.500 796:D27.505.696.663.850.014.040.500 1272:D03.438.759.758.824.651.700  |ES| 2:1 4:1 5:1 9:1 10:1 14:1 19:1 94:1 102:1 163:1 185:1 191:1 249:1 487:1 756:1 1128:1 1662:1 1854:1 1859:1 2367:1 2795:1 4068:1 4497:1 4498:1 4499:1 4500:1 4501:1 4502:1  |EV| 
-0.58120708893190098365266749169677  |BT| (NP (NP (JJ (Chemopreventive))(NN (agent)))(VP (VBD (reported))(S (NP (NN (mechanism))(VBG (targeting))(NN (epigenome)))(VBP (include))(NP (NN (micronutrient)))(-LRB- (-LRB-))(NP (NP (NP (NN (folate)))(, (,))(NP (NP (NN (selenium)))(, (,))(NP (JJ (retinoic))(NN (acid))))(, (,))(NP (NN (Vit)))))))) |ET|  |BS| 36:G02.111.087.029.538 56:D02.455.426.559.389.657.715 224:D03.438.733.631.400 399:D12.776.660.470 433:F01.470.047 595:G07.203.650.240 652:D20.215.784.249 674:B01.650.510.956 684:D02.065.884.247 692:D02.455.326.146.485.222.222 737:D04.808.105.225.272.962 741:D03.383.663.283.909 770:D02.455.326.271.665.202.495.818.500 833:D27.505.696.706.018 835:D27.505.696.377.605 935:D01.268.185.850 944:D03.383.663.283.266.450.400.375 1001:B01.650.940.800.575.100.401.750 1032:D03.383.663.283.266.450.400 1059:H01.158.703 1295:D12.125.068.665.340 1301:B01.650.940.800.575.100.842.500.444 1302:D02.455.426.559.389.140.450.582 1303:D02.455.426.559.847.562.050.650 1304:B01.650.940.800.575.100.610.100 1305:D27.505.954.122.085.255.135 1306:D27.505.954.122.085 1307:D02.241.081.114.750 1308:D10.212.302.380.410 1309:D02.241.081.114 1310:D02.033.623 1311:D12.125.068.555 1312:D02.886.489 1313:D02.092.782 1314:D08.811.913 1315:D01.875  |ES| 2:1 10:1 14:1 19:1 69:1 81:1 154:1 162:1 380:1 399:1 503:1 616:1 728:1 778:1 993:1 1275:1 1380:1 1712:1 2070:1 2085:1 2379:1 2386:1 2433:1 2458:1 2498:1 2530:1 2566:1 2594:1 2630:1 2704:1 2807:1 2973:1 3219:1 3284:1 3314:1 3371:1 3598:1 3707:1 3758:1 3916:1 3924:1 3972:1 4229:1 4245:1 4613:1 4631:1 4632:1 4633:1 4634:1 4635:1 4636:1 4637:1 4638:1 4639:1 4640:1 4641:1 4642:1 4643:1 4644:1 4645:1 4646:1 4647:1 4648:1 4649:1 4650:1 4651:1 4652:1 4653:1 4654:1 4655:1 4656:1 4657:1 4658:1 4659:1 4660:1 4661:1 4662:1 4663:1 4664:1 4665:1 4666:1 4667:1 4668:1 4669:1 4670:1 4671:1 4672:1 4673:1 4674:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (NP (NN (Coexpression))(NN (K-rasVal12))(NN (TAgWt)))(VP (VBP (produce))(NP (NN (dysplasia))))) |ET| 19:1 203:1 1565:1 5405:1 5406:1 5407:1  |EV| 
-2.3935820283491580084955785423517  |BT| (FRAG (ADVP (RB (Here)))(, (,))(NP (VBD (investigated))(NP (NP (NN (effect))(JJ (erlotinib))(JJ (apoptotic))(NN (signal))(NN (pathway))(NN (H3255))(NN (cell))(NN (EGFR)))(PRN (-LRB- (-LRB-))(NP (NN (L858R)))(-RRB- (-RRB-))))(NN (mutation)))) |ET|  |BS| 18:G05.365.590 39:G04.299.139.160 41:A11 761:G02.111.087.800  |ES| 2:1 10:1 14:1 19:1 34:1 75:1 94:1 187:1 383:1 400:1 403:1 859:1 2223:1 2342:1 4770:1 4865:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (S (S (NP (NN (Levamisole)))(VP (VBD (increased))(NP (NNS (ECs))(JJ (integrin-dependent))(NN (matrix))(NN (adhesion)))))(PRN (, (,))(VP (VBD (inhibited))(NP (NP (NP (NP (NN (proliferation)))(PRN (-LRB- (-LRB-))(NP (CD (-70))(NN (%)))(-RRB- (-RRB-))))(, (,))(NP (NP (VBN (reduced))(NN (expression))(NN (survival))(NN (factor))(NN (clusterin)))(PRN (-LRB- (-LRB-))(NP (CD (-30))(NN (%)))(-RRB- (-RRB-))))(, (,))(NP (NN (endothelin-1))(PRN (-LRB- (-LRB-))(NP (CD (-43))(NN (%)))(-RRB- (-RRB-)))))(, (,))(NP (NN (bcl-2))(PRN (-LRB- (-LRB-))(NP (CD (-34))(NN (%)))(-RRB- (-RRB-))))(, (,))(NP (NP (JJ (endothelial))(NN (NO-synthase)))(PRN (-LRB- (-LRB-))(NP (CD (-32))(NN (%)))(-RRB- (-RRB-))))(NP (NN (pRb))(-LRB- (-LRB-))(NN (Retinoblastoma))(NN (protein))(: (:))))(NP (CD (-89))(NN (%))))(-RRB- (-RRB-))(, (,)))(NP (NP (NP (NP (VBN (increased))(NN (growth))(NN (arrest/death))(NN (signal))(NN (p21)))(PRN (-LRB- (-LRB-))(NP (CD (+73))(NN (%)))(-RRB- (-RRB-))))(NN (bak)))(PRN (-LRB- (-LRB-))(NP (CD (+50))(NN (%)))(-RRB- (-RRB-)))))) |ET|  |BS| 45:G07.700.320.249 54:G05.360.340.024.340.375.500.791.150 96:I03.784 122:C14.280.383 135:C23.550.260 871:D02.886.675.346 920:D12.776.543.750.705.408 1479:D12.776.260.704 1480:D08.811.682.664.500.772.750 1481:D12.644.276.400.225 1482:C23.550.355.274.840 1483:D12.776.395.207 1484:F04.570.200.583  |ES| 2:1 4:1 10:1 14:1 19:1 47:1 102:1 104:1 115:1 151:1 185:1 274:1 299:1 365:1 369:1 452:1 753:1 859:1 1135:1 3088:1 3092:1 3093:1 3491:1 5448:1 5449:1 5450:1 5451:1 5452:1 5453:1 5454:1 5455:1 5456:1 5457:1 5458:1 5459:1 5460:1 5461:1 5462:1 5463:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (NP (JJ (Other))(NN (expression))(NN (alteration)))(VP (VBN (observed))(S (NP (JJ (arsenic-treated))(JJ (male))(NN (mouse))(JJ (newborn))(NN (liver)))(VP (VBD (included))(SBAR (S (NP (NP (NN (overexpression))(NNS (cdk-inhibitors))(NN (stress))(NN (response))(NN (gene)))(PP (VBG (including))(NP (VBN (increased))(NN (expression))(NN (metallothionein-1)))))(VP (VBD (decreased))(NP (NN (expression))(NN (betaine-homocysteine))(NN (methyltransferase))(NN (thioether))(NN (S-methyltransferase)))))))))) |ET|  |BS| 6:G05.360.340.024.340 11:B01.050.150.900.649.865.635.505.500 52:E02 242:A03.620 978:D08.811.913.696.620.682.700.646.500 1158:D01.268.513.249 1462:D08.811.913.555.500.175 1463:D08.811.913.555.500 1464:D01.248.497.158.874 1465:M01.060.703.520 1466:D12.776.556.670  |ES| 9:1 19:1 47:1 52:1 115:1 152:1 202:1 261:1 494:1 561:1 836:1 951:1 1402:1 1528:1 2522:1 2655:1 5375:1 5376:1 5377:1 5378:1 5379:1 5380:1 5381:1 5382:1  |EV| 
-0.4700934929473987722303718328476  |BT| (NP (NP (NN (Repression))(NN (MUC2))(NN (gene))(NN (expression))(NN (butyrate)))(, (,))(NP (JJ (physiological))(NN (regulator))(JJ (intestinal))(NN (cell))(NN (maturation)))) |ET|  |BS| 47:A03.556.124 155:G05.355.310 208:F01.393.821 230:G04 1307:D02.241.081.114.750 1309:D02.241.081.114  |ES| 2:1 9:1 19:1 94:1 109:1 115:1 212:1 235:1 3758:1 3762:1 5042:1 5131:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (NP (JJ (Long-term))(JJ (pharmacological))(NN (MAP))(NN (kinase))(NN (inhibition))(NN (MEK))(NN (inhibitor))(NN (PD98059)))(VP (VBD (induced))(NP (NP (NN (expression))(JJ (terminal))(NN (differentiation))(NN (marker))(NN (ITF)))(, (,))(NP (NN (sucrase-isomaltase)))(, (,))(NP (NN (mucin))(NN (gene))(NN (MUC2)))))) |ET|  |BS| 6:G05.360.340.024.340 43:F01.145.544 71:D12.776.395.560.631 233:D08.811.913.696.620.682.700.565 234:D08.811.913.696.620.682.700.565 478:D08.811.913.696.620.682.700.567 849:G08.686.785.760.769.490.500 1045:D23.050.301.264 1059:H01.158.703 1485:D08.811.277.450.770 1486:V01.185.687  |ES| 2:1 9:1 19:1 103:1 115:1 209:1 212:1 215:1 380:1 412:1 470:1 534:1 3707:1 4968:1 5110:1 5464:1 5465:1 5466:1 5467:1 5468:1  |EV| 
-2.6137887091042557585751637816429  |BT| (S (VP (ADVP (RB (Mechanistically)))(, (,))(VP (VBD (demonstrated))(SBAR (S (NP (NN (EPLE)))(VP (VBD (exerted))(NP (NN (function))(VBG (suppressing))(NN (Wnt))(NN (signaling))(NN (pathway)))))))(, (,))(VP (VBN (evidenced))(NP (NP (JJ (EPLE-mediated))(NN (downregulation))(NN (Wnt))(NN (target))(NN (gene))(NN (c-Myc)))(, (,))(NP (NN (Axin2))(NN (Survivin))))))) |ET|  |BS| 6:G05.360.340.024.340 85:G02.111.087.225 147:G02.149.115.800.925  |ES| 2:1 9:1 19:1 33:1 160:1 195:1 308:1 383:1 595:1 824:1 877:1 1175:1 2102:1 2250:1 2489:1 3779:1 5000:1 5001:1 5002:1  |EV| 
-3.2009816039862366565671436546836  |BT| (NP (NP (NP (NN (Dependence))(NNS (diaminothiazoles)))(, (,))(NP (NN (compound)))(VP (VBD (gained))(NP (NP (NP (NP (NN (importance)))(ADJP (RB (recently))(JJ (due))))(JJ (anticancer))(JJ (anti))(JJ (angiogenic))(NN (activity)))(, (,))(NP (NP (VBN (tested))(NN (cancer))(NN (model)))(VP (VBG (varying))(NP (NN (p53))(NN (Ras/Raf))(JJ (mutational))(NN (status))))))))) |ET|  |BS| 1:G05.360.340.024.340.375.500.791.550 2:G05.360.340.024.340.375.249.385 18:G05.365.590 1517:F01.752.330  |ES| 2:1 12:1 18:1 19:1 72:1 399:1 416:1 772:1 1244:1 1660:1 1880:1 2433:1 2851:1 2988:1 3790:1 5470:1 5607:1 5608:1 5609:1 5610:1 5611:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (NP (NN (Curcumin)))(VP (VBZ (sensitizes))(NP (NP (JJ (human))(JJ (colorectal))(NN (cancer))(NN (xenograft))(JJ (nude))(NN (mouse))(NN (gamma-radiation)))(VP (VBG (targeting))(NP (JJ (nuclear))(JJ (factor-kappaB-regulated))(NN (gene))(NN (product))))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 30:Z01.058.290.190.800 31:D08.811.520.224.800 55:B01.050.150.900.649.801.400.112.400.400 88:B01.050.150.900.649.865.635.505.500.550.500 92:E04.936.764 93:A01.941.875 142:I01.880.604 210:D12.776.260.600 692:D02.455.326.146.485.222.222 816:G01.358.500.505.300 973:E05.393.335  |ES| 9:1 17:1 18:1 19:1 36:1 52:1 265:1 266:1 616:1 675:1 1256:1 2062:1 3429:1 3430:1 3431:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (NP (NNP (CAPE))(CC (plus))(NNP (DEN)))(VP (VBD (diminished))(NP (NP (NN (expression))(NN (cytochrome))(VBN (involved))(NN (DEN))(NN (bioactivation))(NN (CYP2B1)))(VP (ADVP (RB (well)))(NP (NP (NN (expression))(NN (regulator))(JJ (oxidative))(NN (stress))(NN (glutathione))(NN (reductase)))(, (,))(NP (NN (GST-kappa))(NN (GST-theta)))(, (,))(NP (NN (cell))(NN (cycle))(NN (regulator)))(NP (NN (p53)))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 7:D12.776 30:Z01.058.290.190.800 31:D08.811.520.224.800 155:G05.355.310 353:G04.299.134 716:G03.495.710 1470:D08.244.453.040.550 1471:D08.811.682.667.092 1472:D08.244  |ES| 2:1 4:1 9:1 12:1 19:1 94:1 96:1 115:1 162:1 235:1 569:1 601:1 637:1 693:1 712:1 774:1 787:1 831:1 900:1 911:1 1719:1 1875:1 2332:1 2353:1 2522:1 2583:1 2744:1 3045:1 3146:1 3374:1 3788:1 4156:1 4350:1 4720:1 4888:1 5399:1 5400:1 5401:1 5402:1 5403:1 5404:1  |EV| 
-1.4053330563954204990295693278313  |BT| (SINV (PP (IN (By))(NP (NN (sequencing))(NN (Apc))(NN (Ctnnb1))(NN (gene))))(, (,))(VBD (found))(S (S (NP (JJ (PhIP-induced))(JJ (small))(JJ (intestinal))(NN (tumor))(JJ (obese))(NN (mouse)))(VP (VBD (carried))(NP (JJ (single))(JJ (heterozygous))(NN (mutation))(NN (Apc)))(PP (IN (By))(NP (JJ (bisulfite-sequencing))(NN (CpG))(NN (island))(NN (Apc))))))(, (,))(VP (VBD (found))(NP (NP (NN (DNA))(NN (hypermethylation))(NN (CpG))(NN (cluster))(JJ (located))(NN (transcription))(NN (initiation))(NN (site)))(, (,))(SBAR (S (ADVP (JJ (likely)))(VP (VBD (caused))(NP (NN (inactivation))(JJ (wild-type))(NN (Apc))(NN (allele)))))))))) |ET|  |BS| 3:C04.557.470.035.215.100 6:G05.360.340.024.340 8:C04 18:G05.365.590 23:D12.776.091.249 25:G02.111.570.080 26:G02.111.570.080 27:G02.111.570.080 38:Z01.058.290.120.180 40:Z01.542.248.700 77:G05.360.340.024.340.030 157:G05.380.383 195:G02.111.570.080.380.160 198:D13.444.308 218:A03.556.124.684 247:G01.374.676.530 765:B01.050.150.900.649.865.635.505.500.550.530 805:F01.829.263.315.500.725 806:F01.829.263.315.500.725 1515:G05.360.340.024.340.137.750.840 1516:G02.111.570.080.380.160  |ES| 2:1 7:1 8:1 9:1 19:1 34:1 37:1 52:1 109:1 230:1 280:1 487:1 637:1 662:1 663:1 664:1 666:1 750:1 786:1 1003:1 1314:1 1328:1 1839:1 1868:1 2205:1 2468:1 2506:1 2846:1 4032:1 4435:1 5580:1 5581:1 5582:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (NNS (Mutations))(NP (NN (codon))(NP (CD (13))(CD (117))(CC (plus))(NP (JJ (second))(NN (exon))(NN (insert)))))(VP (VBD (contributed))(NP (CD (4))(NN (%)))(NP (JJ (total))(JJ (H-ras))(NN (frequency))(NN (trichloroethylene))(NN (tetrachloroethylene))))) |ET|  |BS| 1:G05.360.340.024.340.375.500.791.550 18:G05.365.590 113:C04.697.650 179:D01.248.497.300.459.700 335:D13.444.735.544.355 372:G05.360.340.024.340.137.232 1235:D02.455.526.439.939 1236:D02.455.526.439.880  |ES| 19:1 319:1 369:1 1119:1 1247:1 1255:1 1410:1 1532:1 2347:1 3132:1 4416:1 4888:1 5473:1 5474:1 5475:1 5476:1 5477:1  |EV| 
-3.2008034674454393098130822181702  |BT| (S (ADVP (RB (Nevertheless)))(, (,))(NP (NN (extent))(NN (NAG-1))(NN (induction)))(VP (MD (could))(NP (VBN (altered))(NN (ERK))(NN (inhibitor))(NN (PD98059))))) |ET| 2:1 19:1 380:1 693:1 736:1 908:1 1662:1 4486:1 4968:1 5046:1 5047:1  |EV| 
-1.9066370767520428586294656270184  |BT| (S (S (NP (NN (Pretreatment))(NN (p38))(NN (kinase))(NN (inhibitor)))(VP (VBD (blocked))(NP (JJ (VES-induced))(NN (increase))(NN (NAG-1))(NN (protein))(NN (mRNA))(NN (level)))))(, (,))(IN (whereas))(NP (NP (NN (inhibition))(NN (protein))(NN (kinase))(NN (C)))(, (,))(NP (NN (Akt)))(, (,))(FRAG (NN (c-Jun))(NNP (NH))(LST (-LRB- (-LRB-))(LS (2))(-RRB- (-RRB-)))(: (-))(NP (NP (JJ (terminal))(NN (kinase)))(, (,))(NP (NP (NN (MEK))(NN (activity))(NN (effect)))(JJ (VES-induced))(NN (NAG-1))(NN (level))))))) |ET|  |BS| 7:D12.776 12:Z01.542.049 13:D01.339.387 43:F01.145.544 111:D13.444.735.544 122:C14.280.383 233:D08.811.913.696.620.682.700.565 234:D08.811.913.696.620.682.700.565 378:D08.811.913.696.620.682.700.755 469:D08.811.913.696 470:C02.782.160.927 992:D08.811.913.696.620.682.700.725 1406:D02.455.526.728.650.529  |ES| 2:1 4:1 10:1 14:1 19:1 40:1 75:1 103:1 148:1 249:1 325:1 372:1 380:1 399:1 470:1 1289:1 1661:1 1662:1 1666:1 1686:1 1955:1 2777:1 5107:1 5108:1 5109:1 5110:1  |EV| 
3.2009816039862366565671436546836  |BT| (FRAG (NP (NP (NP (NN (PhIP))(NN (diet)))(NP (ADJP (JJR (>))(ADJP (CD (43))(NN (week))))(NP (JJ (present))(NN (colon))(NN (tumor))(JJ (specific))(CD (-1))(NN (G))(NN (mutation)))))(PP (IN (within))(NP (QP (CD (5))('' (')))(: (-))(NN (GGGA-3))('' ('))(NN (sequence))(NN (APC))))(: (:)))(NP (NN (gene)))) |ET|  |BS| 3:C04.557.470.035.215.100 6:G05.360.340.024.340 18:G05.365.590 26:G02.111.570.080 51:C04.588.274.476.411.307.180 595:G07.203.650.240 596:E02.642.249  |ES| 7:1 9:1 11:1 19:1 34:1 104:1 113:1 293:1 540:1 783:1 1307:1 1466:1 1489:1 2122:1 2191:1 2641:1 5501:1 5502:1 5503:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (NP (NNP (Assessment))(NN (effect))(NN (betaine))(NN (p16))(NN (c-myc))(NN (DNA))(NN (methylation))(NN (mRNA))(NN (expression))(NN (chemical)))(VP (VBD (induced))(NP (NN (rat))(NN (liver))(NN (cancer))(NN (model))))) |ET|  |BS| 111:D13.444.735.544 203:G05.360.340.024.340.375.249.375 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 366:G02.111.087.029.538.161 743:D02.092.877.883.077 838:E05.599.495  |ES| 18:1 19:1 72:1 75:1 81:1 115:1 325:1 412:1 455:1 666:1 836:1 849:1 1313:1 2124:1 2636:1 5393:1  |EV| 
-2.3638664004010934149846434593201e-07  |BT| (NP (NP (RB (Regardless))(NN (p53))(NN (status)))(, (,))(NP (NN (celecoxib)))(VP (VBD (caused))(NP (NP (JJ (significant))(NN (difference))(NN (apoptosis))(NN (level))(NN (U87MG)))(, (,))(NP (NN (U87MG-PFT)))(, (,))(NP (NN (U87MG-E6))(NN (U373MG))(NN (cell)))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 13:D01.339.387 39:G04.299.139.160 41:A11 684:D02.065.884.247  |ES| 2:1 12:1 19:1 89:1 94:1 135:1 249:1 416:1 1674:1 2506:1 2807:1 4619:1 4620:1 4621:1 4623:1 5120:1  |EV| 
-1.4950956498221898982592392712831  |BT| (S (ADVP (RB (Moreover)))(, (,))(S (NP (NN (curcumin)))(VP (VBD (suppressed))(NP (NP (NN (NF-kappaB))(NN (activity))(NN (expression))(JJ (NF-kappaB-regulated))(NN (gene))(NN (product)))(PRN (-LRB- (-LRB-))(NP (NP (NN (cyclin))(NN (D1)))(, (,))(NP (NN (c-myc)))(, (,))(NP (NN (Bcl-2)))(, (,))(NP (NN (Bcl-xL)))(, (,))(NP (JJ (cellular))(NN (inhibitor))(NN (apoptosis))(NN (protein-1)))(, (,))(NP (NN (cyclooxygenase-2)))(, (,))(NP (NN (matrix))(NN (metalloproteinase-9)))(, (,))(NP (JJ (vascular))(JJ (endothelial))(NN (growth))(NN (factor))))(-RRB- (-RRB-))))))(, (,))(NP (JJ (many)))(VP (VBD (induced))(SBAR (S (NP (NN (radiation))(NN (therapy)))(VP (VBP (mediate))(NP (NN (radioresistance)))))))) |ET|  |BS| 7:D12.776 24:D08.811.600.720.750 41:A11 54:G05.360.340.024.340.375.500.791.150 142:I01.880.604 155:G05.355.310 210:D12.776.260.600 215:D12.644.360.262.150.100 281:E02.815 371:A07.231 586:D08.811.277.656.300.480.205.360 692:D02.455.326.146.485.222.222 1130:D12.644.276.390  |ES| 2:1 9:1 10:1 14:1 19:1 61:1 89:1 102:1 115:1 130:1 158:1 185:1 307:1 380:1 399:1 412:1 455:1 622:1 675:1 714:1 743:1 744:1 1040:1 1251:1 1601:1 2157:1 2498:1 2500:1 2501:1 3074:1 3092:1 3491:1 4814:1 5032:1 5033:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (ADVP (RB (Moreover)))(, (,))(NP (NN (inhibition))(NN (autophagy))(NN (sensitization))(NN (cisplatin))(NN (NAC1))(NN (knockdown))(NN (inactivation)))(VP (VBN (accompanied))(NP (NN (induction))(NN (apoptosis))))) |ET|  |BS| 39:G04.299.139.160 43:F01.145.544 390:G04.299.139.399 498:D01.210.375  |ES| 2:1 19:1 89:1 103:1 464:1 622:1 736:1 1314:1 1317:1 1761:1 2137:1 2801:1 5471:1  |EV| 
-0.58940253338562342833029106259346  |BT| (S (NP (NP (NN (Cyp2b20)))(, (,))(NP (NN (growth))(NN (arrest)))(: (-))(NP (NP (JJ (damage-inducible))(NN (gene))(NN (beta)))(PRN (-LRB- (-LRB-))(NP (NN (Gadd45beta)))(-RRB- (-RRB-))))(, (,))(NP (NP (ADJP (NN (tumor))(NN (necrosis))(NN (factor))(JJ (alpha-induced)))(NN (protein))(CD (2))(JJ (insulin-like))(NN (growth))(NN (factor))(NN (binding))(NN (protein))(CD (1)))(PRN (-LRB- (-LRB-))(NP (NN (Igfbp5)))(-RRB- (-RRB-))))(NP (NN (gene))(NN (protein))))(VP (VP (VBD (upregulated))(NP (NN (oxazepam))(, (,))(NN (Cyp2b20))(, (,))(NN (Cyclin))(NN (D1)))(, (,))(S (VP (VBG (proliferating))(NP (NP (NP (NN (cell))(JJ (nuclear))(NN (antigen)))(, (,))(NP (NN (Igfbp5)))(, (,)))(NP (NP (NN (Gadd45beta))(NN (cell))(JJ (death-inducing))(NN (DNA))(NN (fragmentation))(NN (factor))(NN (alpha))(JJ (subunit-like))(NN (effector)))(DT (A)))))))(VP (VBD (exhibited))(NP (JJR (higher))(NN (expression))(NN (Wy-14,643))(NN (treatment)))))) |ET|  |BS| 6:G05.360.340.024.340 7:D12.776 45:G07.700.320.249 52:E02 134:G04.299.139 175:J01.897.280.500.269 198:D13.444.308 215:D12.644.360.262.150.100 583:D12.776.813 768:D12.776.660.740 789:D12.644.276.374.500.800 790:D12.644.276.374.750 1327:D12.776.157.420.250 1328:D06.472.699.322.326.562 1329:D03.438.079.080.070.663 1330:G05.355.180.230  |ES| 2:1 4:1 7:1 9:1 10:1 14:1 19:1 69:1 94:1 98:1 102:1 115:1 125:1 148:1 170:1 185:1 546:1 570:1 609:1 666:1 744:1 1030:1 1256:1 1487:1 1836:1 1972:1 2093:1 2865:1 4173:1 4257:1 4735:1 4736:1 4737:1 4738:1 4739:1 4740:1 4741:1 4742:1 4743:1 4744:1 4745:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (PP (IN (In))(NP (NN (HT-29))(NN (cell))))(, (,))(NP (NN (pterostilbene)))(VP (VBD (reduced))(SBAR (S (NP (NP (NN (protein))(NN (level))(NN (beta-catenin)))(, (,))(NP (NN (cyclin))(NN (D1))(NN (c-MYC)))(, (,))(NP (JJ (altered))(JJ (cellular))(NN (localization))(NN (beta-catenin))))(VP (VBD (inhibited))(NP (NN (phosphorylation))(NN (p65)))))))) |ET|  |BS| 7:D12.776 23:D12.776.091.249 32:C04.697.098.500 33:C04.697.098 41:A11 46:A03.556.124.526.356 122:C14.280.383 158:D23.101 183:G04.299.233.750 215:D12.644.360.262.150.100 792:A11.251.210.190.475 972:G02.111.087.677  |ES| 2:1 4:1 18:1 19:1 60:1 78:1 94:1 113:1 159:1 216:1 244:1 249:1 299:1 365:1 378:1 452:1 534:1 625:1 658:1 693:1 743:1 744:1 787:1 793:1 796:1 827:1 1474:1 1659:1 2250:1 2428:1 2430:1 2484:1 2782:1 3074:1 3426:1 5016:1  |EV| 
-2.5632201191540389118017628788948  |BT| (S (NP (NP (JJ (CRC-associated))(NN (symptom))(NN (patient)))(PP (VBG (including))(NP (JJ (intestinal))(NN (bleeding))(NN (anaemia)))))(ADVP (RB (faithfully)))(VP (VBD (mimicked))(NP (NP (NP (JJ (AOM-treated))(NN (MybER))(JJ (transgenic))(NN (mouse)))(VBN (implicated))(NN (hypoxia))(NN (vessel))(NN (leakage)))(VP (VBG (identifying))(NP (ADJP (ADJP (JJ (additional)))(ADJP (JJ (pathogenic))))(NN (role))(NN (Myb))))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 12:Z01.542.049 15:F01.829.316.616 47:A03.556.124 50:M01.643 52:E02 99:B01.050.050.136.500 132:D02.172.080 327:G06.930 371:A07.231 1011:C23.888.852.079 1322:C15.378.071 1323:C23.550.414  |ES| 19:1 31:1 52:1 109:1 120:1 285:1 561:1 977:1 980:1 1698:1 2474:1 4710:1 4711:1 4712:1 4713:1 4714:1 4715:1 4716:1 4717:1 4718:1 4719:1 4720:1 4721:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (NP (NN (Panobinostat))(NN (treatment)))(VP (VBD (induced))(NP (NP (NP (NN (downregulation))(NN (EGFR)))(, (,))(NP (NN (HER2)))(, (,)))(NN (HER3))(ADJP (NN (mRNA))(NN (protein))(JJ (transcriptional))(JJ (posttranslational)))(NN (mechanism))))) |ET|  |BS| 7:D12.776 52:E02 63:G05.360.340.024.340.375.500.791.295.305 65:D08.811.913.696.620.682.725.400.009.400 85:G02.111.087.225 111:D13.444.735.544 209:G02.111.087.847  |ES| 2:1 4:1 19:1 162:1 187:1 188:1 325:1 412:1 546:1 559:1 595:1 4961:1 5499:1 5500:1  |EV| 
-2.0404643970905453898012638092041  |BT| (S (ADVP (RB (Furthermore)))(, (,))(NP (NN (PSI))(NN (treatment)))(VP (VBD (increased))(NP (NN (level))(NN (Bax)))(, (,))(SBAR (S (NP (NP (NN (cytochrome))(NN (c)))(, (,))(NP (VBN (activated))(NN (caspase-3)))(, (,))(NP (JJ (active))(NN (caspase-9)))(, (,))(NP (NP (VBN (cleaved))(NN (poly)))(PRN (-LRB- (-LRB-))(NP (NN (ADP-ribose)))(-RRB- (-RRB-))))(NP (NN (polymerase))))(VP (VBD (decreased))(NP (NP (NN (Bcl-2))(NN (expression))(NN (level)))(NP (JJ (extracellular))(JJ (signal-regulated))(NN (kinase-1))(: (/))(CD (2))(NN (activity))))))))) |ET|  |BS| 52:E02 54:G05.360.340.024.340.375.500.791.150 116:D08.811.913.696.620.682.700.567.249.750 342:D12.644.360.075.718.400 906:D08.811.277.656.262.500.126.350.300 1248:D08.811.913.400.725.115.690 1337:D08.244.286.100 1338:D08.244.286.150 1349:D08.811.277.656.262.500.126.550.900  |ES| 2:1 10:1 14:1 19:1 47:1 115:1 158:1 163:1 197:1 202:1 249:1 334:1 394:1 399:1 546:1 1707:1 3788:1 4630:1 4777:1 4806:1 4807:1 4808:1 4809:1 4810:1 4811:1 4812:1 4813:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (NP (NNS (METHODS))(: (:)))(PP (IN (In))(NP (NN (study))))(VP (VBD (used))(NP (NP (NN (p53)))(VP (VBN (mutated))(VP (VB (knock))(S (NP (NP (NN (colon))(NN (cancer))(NN (cell))(NN (xenograft))(NN (tumour))(NN (study)))(NN (role))(NN (p53))(NN (apoptosis)))(VP (VBD (mediated))(NP (NNS (diaminothiazoles)))))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 8:C04 15:F01.829.316.616 30:Z01.058.290.190.800 31:D08.811.520.224.800 39:G04.299.139.160 41:A11 92:E04.936.764 93:A01.941.875 168:E05.581  |ES| 12:1 18:1 19:1 31:1 89:1 94:1 104:1 113:1 131:1 229:1 244:1 265:1 437:1 476:1 565:1 1011:1 5469:1 5470:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (NP (NN (OBJECTIVE))(: (:)))(NP (NN (FBXW7)))(VP (VBZ (encodes))(NP (SBAR (S (NP (JJ (substrate))(NN (recognition))(NN (component))(NN (ubiquitin))(NN (ligase)))(VP (VBZ (degrades))(NP (NN (target))(NN (Notch1))))))(, (,))(NP (NN (c-Jun)))(, (,))(NP (NN (c-Myc))(NN (cyclin))(NN (E)))))) |ET|  |BS| 415:F01.658.500 1458:D12.644.360.262.180 1491:F02.463.425.540.706 1492:D12.776.947.500 1493:D08.811.464  |ES| 2:1 19:1 104:1 160:1 651:1 743:1 824:1 1021:1 1417:1 1686:1 2085:1 2211:1 3470:1 3757:1 5127:1 5482:1 5483:1 5484:1  |EV| 
-3.1488843695825643465013854438439  |BT| (S (ADVP (RB (However)))(, (,))(NP (JJ (combined))(NN (effect))(NN (mda-7))(NN (sulindac)))(ADVP (RB (previously)))(VP (VBN (tested)))) |ET|  |BS| 251:D02.455.426.559.847.486.875  |ES| 2:1 19:1 75:1 164:1 433:1 869:1 1527:1 2988:1 5657:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (ADVP (RB (Furthermore)))(, (,))(NP (NN (UDCA)))(VP (VBD (inhibited))(NP (NP (NN (Cox-2))(NN (induction))(JJ (Ras-dependent)))(: (-))(NP (JJ (independent))(NN (mechanism)))))) |ET|  |BS| 1:G05.360.340.024.340.375.500.791.550 122:C14.280.383 737:D04.808.105.225.272.962  |ES| 2:1 19:1 62:1 162:1 334:1 365:1 736:1 2631:1 5425:1 5426:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (PP (IN (In))(NP (NN (addition))))(, (,))(NP (NN (IBN-65)))(VP (VP (VBD (induced))(NP (NP (NN (apoptosis)))(NP (JJ (down-regulating))(NNP (Survivin)))))(, (,))(NP (NP (NN (Bcl-2))(VBG (up-regulating))(NN (Bax)))(, (,))(VP (VBG (leading))(NP (JJ (sequential))(NN (activation))(NN (Caspase-3))))(, (,))(NP (NP (NN (Caspase-9))(NN (cleavage))(NN (poly))(-LRB- (-LRB-))(NN (ADP-ribose))(-RRB- (-RRB-))(NN (polymerase)))(PRN (-LRB- (-LRB-))(NP (NN (PARP)))(-RRB- (-RRB-))))))) |ET|  |BS| 39:G04.299.139.160 54:G05.360.340.024.340.375.500.791.150 86:D01.268.556.435 150:Z01.542.248.960 342:D12.644.360.075.718.400 351:A17.360 906:D08.811.277.656.262.500.126.350.300 1248:D08.811.913.400.725.115.690 1349:D08.811.277.656.262.500.126.550.900 1440:G04.299.134.220.250  |ES| 2:1 10:1 14:1 19:1 89:1 158:1 225:1 244:1 394:1 412:1 468:1 639:1 1876:1 3097:1 3190:1 3779:1 4630:1 4810:1 4811:1 5247:1 5438:1 5439:1 5440:1 5441:1  |EV| 
-3.2009816039855891744991822633892  |BT| (S (PP (IN (In))(NP (NN (addition))))(, (,))(NP (NN (reporter))(NN (assay)))(VP (VBD (indicated))(SBAR (S (NP (NN (FXRE))(NN (promoter))(NN (activity)))(ADVP (RB (significantly)))(VP (VBD (increased))(NP (NP (NN (treatment))(NN (ACR)))(CC (plus))(NP (NN (GW4064))))))))) |ET|  |BS| 52:E02 106:E05.091  |ES| 2:1 19:1 47:1 83:1 124:1 244:1 288:1 310:1 399:1 468:1 546:1 1541:1 4503:1 4504:1 4887:1 4888:1  |EV| 
-3.2009816039856104907812550663948  |BT| (S (NP (PRP (It)))(VP (VBD (augmented))(SBAR (S (NP (NN (caspase-3))(NN (activity)))(VP (VBD (downregulated))(NP (NP (NN (expression))(NN (Bcl-2)))(, (,))(NP (NN (Bcl-xL)))(, (,))(NP (NN (cIAP1))(NN (cFLIP))))))))) |ET|  |BS| 54:G05.360.340.024.340.375.500.791.150 906:D08.811.277.656.262.500.126.350.300  |ES| 2:1 19:1 115:1 158:1 399:1 426:1 1327:1 4807:1 4814:1 4979:1 4980:1 4981:1  |EV| 
-5.4693850870535243302583694458008e-07  |BT| (S (ADVP (RB (Furthermore)))(, (,))(NP (NN (cancer))(NN (cell)))(VP (VBD (showed))(SBAR (S (NP (VBN (increased))(NN (level))(VBN (activated))(NN (caspase-3)))(VP (VBD (increased))(NP (NN (Bax))(NN (Bcl-2))(NN (Bax))(NN (Bcl-xL))(NN (ratio)))(, (,))(S (VP (VBG (suggesting))(NP (NP (NN (cell)))(VP (VBG (undergoing))(NP (NN (apoptosis)))))))))))) |ET|  |BS| 39:G04.299.139.160 41:A11 54:G05.360.340.024.340.375.500.791.150 342:D12.644.360.075.718.400 906:D08.811.277.656.262.500.126.350.300  |ES| 2:1 18:1 19:1 47:1 89:1 94:1 132:1 158:1 163:1 249:1 334:1 1009:1 2940:1 4630:1 4807:1 4814:1 4815:1  |EV| 
-3.2009816039862366565671436546836  |BT| (S (PP (IN (In))(NP (NN (study))))(, (,))(VP (VBD (identified))(NP (NP (JJ (novel))(NN (CEBPD))(NN (activator)))(, (,))(NP (NP (LST (LS (1))(: (-)))(-LRB- (-LRB-))(JJ (2-hydroxy-5-methylphenyl))(-RRB- (-RRB-))(NN (-3-phenyl-1,3-propanedione)))(PRN (-LRB- (-LRB-))(NP (NN (HMDB)))(-RRB- (-RRB-))))))) |ET|  |BS| 259:D12.776.395.240.150.500  |ES| 2:1 10:1 14:1 19:1 131:1 244:1 623:1 861:1 891:1 5667:1 5668:1 5669:1 5670:1 5671:1  |EV| 
-2.2504724767144921315775718539953  |BT| (S (NP (JJ (DEN-induced))(NN (rat)))(VP (VBD (exhibited))(NP (NP (VBN (increased))(NN (gene))(NN (expression))(NN (NF-kappaB)))(, (,))(NP (NN (COX-2)))(, (,))(NP (NN (CYP2E1)))(, (,))(NP (NN (VEGF)))(, (,))(NP (NN (Bcl-2)))(, (,))(NP (NN (PI3K/AKT/mTOR))))(S (ADVP (RB (significantly)))(VP (VBD (decreased))(NP (NP (NN (gene))(NN (expression))(NN (p53)))(, (,))(NP (NN (Bax)))(, (,))(NP (NN (caspase-9))(NN (caspase-3)))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 54:G05.360.340.024.340.375.500.791.150 155:G05.355.310 175:J01.897.280.500.269 210:D12.776.260.600 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 342:D12.644.360.075.718.400 378:D08.811.913.696.620.682.700.755 906:D08.811.277.656.262.500.126.350.300 1218:D08.244.453.300 1290:D08.811.913.696.620.500 1349:D08.811.277.656.262.500.126.550.900  |ES| 2:1 9:1 12:1 19:1 47:1 76:1 115:1 124:1 158:1 202:1 609:1 714:1 849:1 2066:1 2735:1 4270:1 4630:1 4807:1 4808:1 5606:1  |EV| 
-1.6976793039499824544691364280879  |BT| (S (NP (NN (Curcumin)))(VP (VBD (suppressed))(NP (NP (NP (NN (expression))(NN (protein))(JJ (related))(NN (cell))(NN (survival)))(PRN (-LRB- (-LRB-))(NP (NN (bcl-2))(NN (bcl-xL)))(-RRB- (-RRB-))))(, (,))(NP (NP (NN (proliferation)))(PRN (-LRB- (-LRB-))(NP (NN (cyclin))(NN (D1))(NN (c-myc)))(-RRB- (-RRB-))))(, (,))(NP (NP (NN (tumor))(NN (invasion)))(NP (NP (-LRB- (-LRB-))(NN (MMP-9))(NN (ICAM-1))(-RRB- (-RRB-))(NN (angiogenesis)))(PRN (-LRB- (-LRB-))(NP (NN (VEGF)))(-RRB- (-RRB-)))))(, (,))(NP (NN (microvessel))(NN (density)))))) |ET|  |BS| 7:D12.776 8:C04 54:G05.360.340.024.340.375.500.791.150 108:G04.299.316 215:D12.644.360.262.150.100 586:D08.811.277.656.300.480.205.360 692:D02.455.326.146.485.222.222 1325:D12.776.395.550.200.450 1326:A07.231.461  |ES| 2:1 4:1 7:1 10:1 14:1 19:1 94:1 115:1 151:1 274:1 299:1 307:1 419:1 455:1 620:1 743:1 744:1 2066:1 2158:1 2502:1 3429:1 4731:1 4732:1 4733:1 4734:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (NP (NN (MicroRNA-122)))(VP (VBZ (inhibits))(SBAR (S (NP (JJ (tumorigenic))(NN (property))(JJ (hepatocellular))(NN (carcinoma))(NN (cell)))(VP (VBZ (sensitizes))(NP (NN (cell))(NN (sorafenib)))))))) |ET|  |BS| 41:A11 104:C04.557.470.200.025.255 122:C14.280.383 184:D13.150.650.319 575:V02.050  |ES| 19:1 94:1 303:1 304:1 615:1 841:1 1797:1 1809:1 2062:1 2063:1  |EV| 
3.2009816039862366565671436546836  |BT| (NP (NP (JJ (Different))(NN (mechanism))(JJ (DEHP-induced))(JJ (hepatocellular))(NN (adenoma))(NN (tumorigenesis))(JJ (wild-type))(NN (Ppar))(JJ (alpha-null))(NN (mouse)))) |ET|  |BS| 29:B01.050.050.136.500.500 32:C04.697.098.500 33:C04.697.098 536:D12.776.826.239.500 911:D02.241.223.805.250 1194:C04.557.470.035.120  |ES| 8:1 19:1 42:1 52:1 78:1 162:1 303:1 5384:1 5385:1 5414:1 5415:1  |EV| 
-3.2009816039862366565671436546836  |BT| (S (NP (NNS (RWPs)))(VP (VBD (reduced))(NP (SBAR (S (NP (NP (NN (expression))(NN (VEGF)))(, (,))(NP (NP (NP (NN (matrix))(NN (metalloproteinase)))(PRN (-LRB- (-LRB-))(NP (NN (MMP)))(-RRB- (-RRB-))))(CD (-2))(, (,))(NN (MMP-9))(, (,))(NN (cyclooxygenase-2))))(VP (VBD (increased))(NP (NN (expression))(NN (tumor))(NN (suppressor))(NN (gene))(NN (p16))(-LRB- (-LRB-))(NN (INK4A))(-RRB- (-RRB-))))))(, (,))(NP (NN (p53))(, (,))(NN (p73))(NN (tumor))(NN (cell)))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 8:C04 24:D08.811.600.720.750 41:A11 155:G05.355.310 203:G05.360.340.024.340.375.249.375 206:G05.360.340.024.340.375.249 586:D08.811.277.656.300.480.205.360 1417:D08.811.277.656.300.480.205.352  |ES| 2:1 7:1 9:1 10:1 12:1 14:1 19:1 47:1 61:1 94:1 115:1 452:1 700:1 1313:1 2066:1 2158:1 2892:1 3182:1 3491:1 5147:1 5148:1 5149:1 5150:1  |EV| 
-3.1649930563240786796086467802525  |BT| (S (NP (NN (HO-3867)))(VP (VBD (induced))(NP (NN (G))(S (-LRB- (-LRB-))(NP (NP (CD (2))(-RRB- (-RRB-))(: (-)))(NP (NP (NN (M))(NN (cell))(NN (cycle))(NN (arrest))(NN (A2780))(NN (cell))(NN (modulating))(NN (cell))(NN (cycle))(JJ (regulatory))(NN (molecule))(NN (p53)))(, (,))(NP (NN (p21)))(, (,))(NP (NN (p27)))(, (,))(NP (JJ (cyclin-dependent))(NN (kinase))(CD (2)))(, (,))(NP (NN (cyclin)))(, (,))))(VP (VBD (promoted))(NP (NN (apoptosis))(NN (caspase-8))(NN (caspase-3))(NN (activation)))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 39:G04.299.139.160 41:A11 353:G04.299.134 768:D12.776.660.740 773:G04.299.134.109 906:D08.811.277.656.262.500.126.350.300 1034:D08.811.277.656.262.500.126.550.800 1280:D12.644.360.262 1365:D08.811.913.696.620.682.700.646.500.750  |ES| 2:1 10:1 12:1 14:1 19:1 89:1 94:1 148:1 180:1 225:1 412:1 470:1 601:1 602:1 743:1 1124:1 1135:1 1817:1 1912:1 2435:1 3016:1 3612:1 4546:1 4807:1 4880:1 4881:1 4882:1  |EV| 
-3.2009816039862366565671436546836  |BT| (S (NP (NP (NN (Protein))(NN (analysis)))(VP (VBN (treated))(NP (NN (tumor))(NN (biopsy)))))(VP (VBD (revealed))(NP (NP (NP (JJ (elevated))(NN (amount))(NN (cell))(NN (cycle))(NN (regulator)))(NP (NN (p21))(NN (proapoptosis))(NN (factor))))(, (,))(NP (NP (NN (caspase))(CD (3)))(CD (7))(VBN (cleaved))(NN (poly))(-LRB- (-LSB-))(NN (ADP-ribose))(-RRB- (-RSB-))(NN (polymerase)))(, (,))(VP (VBN (coupled))(VP (VBN (decreased))(NP (NP (NN (level))(JJ (antiapoptotic))(NN (factor))(NN (Bcl-2))(NN (Bcl-X)))(PRN (-LRB- (-LRB-))(NP (NN (L)))(-RRB- (-RRB-))))))))) |ET|  |BS| 52:E02 54:G05.360.340.024.340.375.500.791.150 353:G04.299.134 418:D12.644.360.075.718.937 559:E01.370.225.500.384.100 906:D08.811.277.656.262.500.126.350.300 1248:D08.811.913.400.725.115.690 1407:D12.776.624  |ES| 2:1 7:1 10:1 14:1 19:1 94:1 158:1 185:1 202:1 235:1 249:1 275:1 394:1 601:1 661:1 709:1 756:1 862:1 988:1 1099:1 1135:1 1373:1 1378:1 1436:1 1984:1 2911:1 4796:1 4809:1 4810:1 4811:1 5111:1 5112:1 5113:1 5114:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (NP (DT (A))(JJ (recent))(NN (study)))(VP (VBD (revealed))(SBAR (S (NP (NP (JJ (long-term))(NN (exposure)))(ADJP (RB (relatively))(JJ (low-dose)))(NN (DEHP))(PRN (-LRB- (-LRB-))(NP (CD (0.05))(NN (%)))(-RRB- (-RRB-))))(VP (VBD (caused))(NP (NP (NN (liver))(NN (tumor)))(PP (VBG (including))(NP (NP (JJ (hepatocellular))(NN (carcinoma)))(, (,))(NP (JJ (hepatocellular))(NN (adenoma)))(, (,))(NP (NP (NP (NP (ADJP (NP (JJ (chologiocellular))(NN (carcinoma)))(JJR (higher)))(NN (incidence))(NN (Ppar))(JJ (alpha-null))(NN (mouse)))(PRN (-LRB- (-LRB-))(NP (CD (25.8))(NN (%)))(-RRB- (-RRB-))))(NP (JJ (wild-type))(NN (mouse))))(PRN (-LRB- (-LRB-))(NP (CD (10.0))(NN (%)))(-RRB- (-RRB-)))))))))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 29:B01.050.050.136.500.500 104:C04.557.470.200.025.255 265:C04.557.470.200 434:E05.318.308.985.525.375 515:C04.588.274.623 536:D12.776.826.239.500 849:G08.686.785.760.769.490.500 911:D02.241.223.805.250 1194:C04.557.470.035.120  |ES| 2:1 7:1 8:1 10:1 14:1 19:1 42:1 52:1 69:1 131:1 170:1 275:1 303:1 304:1 369:1 561:1 659:1 836:1 1511:1 1953:1 2506:1 3049:1 3205:1 3546:1 3849:1 3924:1 5383:1 5384:1 5385:1 5386:1 5387:1  |EV| 
3.2009816039862366565671436546836  |BT| (FRAG (PP (IN (In))(NP (NP (NNP (AOM)))(ADVP (RB (alone)))))(NP (NP (NN (group)))(, (,))(NP (NN (Cox-2)))(VP (VBD (up-regulated))(SBAR (S (NP (ADJP (JJR (>))(JJ (50-fold)))(NN (tumor))(JJ (normal))(NP (NN (Ras)))(NN (activity)))(VP (VBD (enhanced))(NP (NN (tumor))(JJ (mutant))(JJ (signaling-activated))(NN (Ras))))))))) |ET|  |BS| 1:G05.360.340.024.340.375.500.791.550 8:C04 69:G02.111.087.800 132:D02.172.080 142:I01.880.604 150:Z01.542.248.960 829:M01.686  |ES| 2:1 7:1 19:1 62:1 118:1 241:1 244:1 385:1 399:1 811:1 1301:1 1466:1 1775:1 1994:1 2300:1 5443:1 5444:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (PP (IN (In))(NP (NN (HT-29))(NN (cell))))(, (,))(NP (NN (pterostilbene)))(VP (VBD (reduced))(SBAR (S (NP (NP (NN (protein))(NN (level))(NN (beta-catenin)))(, (,))(NP (NN (cyclin))(NN (D1))(NN (c-MYC)))(, (,))(NP (JJ (altered))(JJ (cellular))(NN (localization))(NN (beta-catenin))))(VP (VBD (inhibited))(NP (NN (phosphorylation))(NN (p65)))))))) |ET|  |BS| 7:D12.776 23:D12.776.091.249 41:A11 122:C14.280.383 215:D12.644.360.262.150.100 792:A11.251.210.190.475 972:G02.111.087.677  |ES| 2:1 4:1 19:1 60:1 94:1 244:1 249:1 365:1 452:1 625:1 693:1 743:1 744:1 2428:1 2484:1 2782:1 3074:1 3426:1 5016:1  |EV| 
-0.95742576784550692536868155002594  |BT| (S (NP (DT (This))(NN (research)))(VP (VBZ (provides))(NP (NN (evidence))(NN (tea)))(, (,))(NP (ADVP (RB (particularly)))(NP (VBN (administered))(NN (combination))(NN (sulindac)))(, (,))(NP (PP (ADJP (RB (highly))(JJ (effective)))(S (VP (VBG (inhibiting))(NP (NP (NP (JJ (intestinal))(NN (neoplasia))(NN (male))(NN (Apc)))(PRN (-LRB- (-LRB-))(NP (NN (min)))(-RRB- (-RRB-))))(NN (mouse)))(PP (IN (via))(NP (JJ (direct))(JJ (indirect))(NN (effect))(NN (beta-catenin/APC))(NN (pathway))))))))))) |ET|  |BS| 3:C04.557.470.035.215.100 11:B01.050.150.900.649.865.635.505.500 23:D12.776.091.249 102:C04.588.274.476.411 122:C14.280.383 251:D02.455.426.559.847.486.875 644:H01.770.644 645:H01.770.644  |ES| 2:1 10:1 14:1 19:1 38:1 52:1 75:1 109:1 280:1 383:1 530:1 596:1 626:1 640:1 807:1 815:1 869:1 880:1 1402:1 1639:1 1891:1 2336:1 2378:1 2379:1 2380:1 2381:1 2382:1 2383:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (NP (NN (Hesperidin))(NN (treatment)))(VP (VBD (caused))(SBAR (S (NP (JJ (significant))(NP (NP (NN (up-regulation))(NN (tumour))(NN (suppressor))(NN (phosphatase))(NN (tensin))(NN (homologue)))(PRN (-LRB- (-LRB-))(NP (NN (PTEN)))(-RRB- (-RRB-))))(NN (reduction))(NN (expression))(NNP (AOM)))(VP (VBD (mediated))(NP (NN (p-PI3K))(NN (p-Akt)))))))) |ET|  |BS| 52:E02 132:D02.172.080 142:I01.880.604 206:G05.360.340.024.340.375.249 378:D08.811.913.696.620.682.700.755 1035:D08.811.277.352.650 1290:D08.811.913.696.620.500 1477:D03.383.663.283.266.450.252.500  |ES| 10:1 14:1 19:1 115:1 135:1 226:1 370:1 437:1 546:1 700:1 896:1 1011:1 1936:1 1994:1 2506:1 3619:1 3620:1 5429:1 5430:1 5431:1  |EV| 
3.2009816039862366565671436546836  |BT| (NP (NP (NP (NN (DEN))(NN (treatment))(VBN (modified))(NN (expression))(CD (665))(NN (gene)))(, (,))(NP (NP (NN (CAPE)))(CC (plus))(NP (NN (DEN))))(VP (VBD (induced))(NP (NN (change))(CD (1371))(NN (gene)))))) |ET|  |BS| 6:G05.360.340.024.340 52:E02 155:G05.355.310  |ES| 2:1 9:1 19:1 115:1 200:1 412:1 546:1 1875:1 2332:1 2335:1 4888:1 5412:1 5413:1  |EV| 
-1.1864525921928361640311777591705  |BT| (S (NP (NN (Inhibition))(NN (JNK))(NN (chemical))(JJ (genetic))(NN (method)))(VP (VBD (attenuated))(NP (JJ (NaBT-induced))(NN (PTEN))(NN (expression))))) |ET|  |BS| 43:F01.145.544 1372:E05.393  |ES| 19:1 115:1 808:1 864:1 1599:1 1936:1 2124:1 2703:1 4276:1 4943:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (NP (RB (Only))(NN (10-MeBaA)))(VP (VBD (induced))(S (NP (NP (NN (apoptosis))(NN (accumulation)))(VP (VBN (phosphorylated))(S (NP (NN (p53))))))(, (,))(VP (MD (could))(NP (NP (VBN (associated))(NN (induction))(JJ (oxidative))(NN (stress)))(, (,))(NP (JJ (similar))(NN (DMBA)))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 39:G04.299.139.160 716:G03.495.710 1488:D02.455.426.559.847.149.301  |ES| 2:1 12:1 19:1 89:1 169:1 332:1 412:1 736:1 908:1 2120:1 2522:1 2583:1 4930:1 5490:1 5491:1 5492:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (NP (NN (DEN))(NN (treatment)))(VP (VP (VBD (increased))(NP (NP (NN (expression))(NN (gene)))(VP (VBN (associated))(NP (JJ (oxidative))(NN (stress))(NN (glutathione))(NN (reductase))))))(, (,))(NP (NP (NN (gene))(VBN (involved))(NN (cell))(NN (cycle))(NN (regulation)))(PP (VBG (including))(NP (NP (NN (p53)))(, (,))(NP (VBN (modified))(NN (cytochrome))(NN (P450)))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 6:G05.360.340.024.340 52:E02 155:G05.355.310 716:G03.495.710 1079:D08.244.453 1259:G04.299.134.109 1471:D08.811.682.667.092  |ES| 2:1 9:1 12:1 19:1 47:1 94:1 96:1 115:1 169:1 438:1 546:1 561:1 601:1 774:1 1875:1 2335:1 2522:1 2549:1 2583:1 2744:1 3788:1  |EV| 
-3.2009816039862366565671436546836  |BT| (S (NP (ADJP (FW (In))(FW (vivo)))(NN (treatment))(NN (imatinib)))(ADVP (RB (also)))(VP (VBP (block))(NP (NN (expression))(NN (CD34))(NN (PDGF-C))(NN (Tg))(NN (mouse))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 52:E02 122:C14.280.383  |ES| 5:1 19:1 52:1 115:1 244:1 378:1 546:1 742:1 4916:1 4920:1 4936:1 4937:1  |EV| 
-3.1353514858519133667869027704  |BT| (S (PP (IN (In))(NP (NP (NP (NN (mouse))(JJ (ovarian))(JJ (endometrioid))(NN (adenocarcinoma)))(PRN (-LRB- (-LRB-))(NP (NNS (OEAs)))(-RRB- (-RRB-))))(VP (VBG (arising))(NP (NN (Apc))))))(: (-))(NP (NP (NN (Pten-inactivation)))(, (,))(NP (NN (Ctnnb1))(JJ (hemizygous))(NN (dose))))(VP (VBD (affected))(NP (NP (NN (beta-catenin))(NN (level))(NN (beta-catenin/TCF))(NN (target))(NN (gene)))(, (,))(NP (NN (Myc))(NN (induction))))(VP (VBD (retained))(SBAR (S (NP (NNS (OEAs)))(VP (VBD (arose))(NP (NP (NN (fashion))(JJ (akin)))(VBN (seen))(JJ (intact))(NN (Ctnnb1))(NN (gene))(NN (dose))))))))) |ET|  |BS| 3:C04.557.470.035.215.100 6:G05.360.340.024.340 11:B01.050.150.900.649.865.635.505.500 23:D12.776.091.249 213:F02.830.816.964 433:F01.470.047 1368:C04.557.470.200.025.240 1369:A05.360.319.114.630  |ES| 2:1 9:1 10:1 14:1 19:1 52:1 60:1 160:1 244:1 249:1 255:1 724:1 736:1 1577:1 1763:1 1786:1 2301:1 4032:1 4422:1 4722:1 4754:1 4906:1 4907:1 4908:1 4909:1 4910:1 4911:1 4912:1 4913:1 4914:1  |EV| 
-0.57355116678331796720158308744431  |BT| (S (NP (NN (MBO-asGCS)))(VP (VBD (suppressed))(NP (NP (NN (expression))(NN (MDR1))(NNS (GCS)))(NP (VBN (sensitized))(NN (NCI/ADR-RES))(NN (tumor))(NN (doxorubicin)))))) |ET|  |BS| 8:C04 120:I01.409.418.750.600.480.150 136:D02.455.426.559.847.562.050.200.175  |ES| 7:1 19:1 115:1 307:1 453:1 598:1 599:1 4697:1 4761:1 4764:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (NP (NP (NN (Activation))(JJ (nonsteroidal))(JJ (anti-inflammatory))(JJ (drug-activated))(NN (gene-1)))(PP (IN (via))(NP (JJ (extracellular))(JJ (signal-regulated))(NN (kinase))(CD (1/2))(JJ (mitogen-activated))(NN (protein))(NN (kinase)))))(VP (VBD (revealed))(NP (JJ (isochaihulactone-triggered))(JJ (apoptotic))(NN (pathway))(NP (JJ (human))(NN (lung))(NN (cancer))(NN (A549))(NN (cell)))))) |ET|  |BS| 39:G04.299.139.160 41:A11 55:B01.050.150.900.649.801.400.112.400.400 264:G05.355.315.800 469:D08.811.913.696 477:D08.811.913.696.620.682.700.567.249 573:N05.715.350.200.650 796:D27.505.696.663.850.014.040.500  |ES| 4:1 18:1 19:1 36:1 87:1 94:1 275:1 328:1 364:1 383:1 470:1 596:1 1707:1 1859:1 2223:1 2795:1 3046:1 3295:1 4812:1 4966:1 4978:1 5388:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (NP (NNP (Nestin))(NN (silencing)))(VP (ADVP (RB (also)))(VP (VBD (upregulated))(NP (NP (NN (Axin))(, (,))(NP (NP (NN (glycogen))(NN (synthase))(NN (kinase-3))(NN (beta)))(PRN (-LRB- (-LRB-))(NP (NN (GSK-3beta)))(-RRB- (-RRB-))))(, (,))(NP (JJ (adenomatous))(NN (polyposis))(NN (coli))(PRN (-LRB- (-LRB-))(NP (NN (APC)))(-RRB- (-RRB-))))(, (,)))(NP (NP (NN (peroxisome))(JJ (proliferator-activated))(NN (receptor))(NN (alpha)))(PRN (-LRB- (-LRB-))(NP (NN (PPARa)))(-RRB- (-RRB-))))))(, (,))(VP (VBD (downregulated))(NP (NP (NN (beta-catenin)))(, (,))(NP (NN (c-Myc)))(, (,))(NP (NP (NN (cyclin))(NN (D)))(NN (MMP-7))(NN (expression))(NNP (CSC))))))) |ET|  |BS| 3:C04.557.470.035.215.100 21:G05.360.340.024.340.375.249.050 23:D12.776.091.249 536:D12.776.826.239.500 556:C11.768.175 937:D08.811.277.656.300.480.525.700.250 1046:D12.644.360.262.150 1047:D05.750.078.593.540  |ES| 2:1 5:1 10:1 11:1 14:1 19:1 57:1 58:1 59:1 60:1 66:1 92:1 100:1 115:1 125:1 186:1 426:1 743:1 824:1 1801:1 1836:1 1887:1 1972:1 2592:1 3577:1 3650:1 3651:1 3652:1 3653:1 3654:1 3655:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (PP (IN (In))(NP (NN (addition))))(, (,))(NP (NN (metformin)))(VP (VBD (induced))(NP (NP (NN (apoptosis))(NN (OSCC))(NN (cell)))(, (,))(VP (ADVP (RB (significantly)))(VBG (down-regulating))(NP (NP (JJ (anti-apoptotic))(NN (protein))(NN (Bcl-2))(NN (Bcl-xL)))(VP (VBG (up-regulating))(NP (JJ (pro-apoptotic))(NN (protein))(NN (Bax))))))))) |ET|  |BS| 39:G04.299.139.160 41:A11 54:G05.360.340.024.340.375.500.791.150 150:Z01.542.248.960 342:D12.644.360.075.718.400 351:A17.360 784:D02.078.370.141.450 1469:D12.644.360.075  |ES| 2:1 4:1 19:1 89:1 94:1 124:1 158:1 244:1 412:1 468:1 1876:1 3097:1 4630:1 4814:1 5087:1 5230:1 5232:1 5442:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (ADVP (RB (Notably)))(, (,))(NP (NN (AcEGCG)))(VP (VP (VBD (inhibited))(NP (NP (NN (expression))(NN (p53))(, (,))(NN (p21))(, (,))(NN (c-Myc))(, (,))(NN (cyclin))(NN (B)))(, (,))(NP (NN (p-CDK1))(NN (Cdc25A))))(ADVP (RB (also)))(VP (VBD (restored))(NP (NN (activation))(NP (NP (JJ (extracellular))(JJ (signal-regulated))(NN (kinase))(CD (1/2)))(PRN (-LRB- (-LRB-))(NP (NN (ERK1/2)))(-RRB- (-RRB-)))))))(, (,))(VP (VBD (decreased))(NP (JJ (DMBA/TPA-induced))(NN (increase))(NN (tumor))(NN (proliferation))(JJ (mitotic))(NN (index)))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 8:C04 116:D08.811.913.696.620.682.700.567.249.750 122:C14.280.383 212:E01.370.225.500.385.500 1487:D08.811.913.696.620.682.700.646.500.500.250 1488:D02.455.426.559.847.149.301 1489:D08.811.277.656.300.760.875 1490:D12.644.360.262.120  |ES| 2:1 5:1 7:1 10:1 12:1 14:1 19:1 40:1 115:1 202:1 225:1 299:1 365:1 470:1 720:1 721:1 743:1 763:1 824:1 1135:1 1707:1 2798:1 4594:1 4812:1 4893:1 4966:1 5478:1 5479:1 5480:1 5481:1  |EV| 
-0.00022955708547556241683196276426315  |BT| (S (NP (NN (Glucosylceramide))(NN (synthase)))(VP (VBZ (upregulates))(NP (NN (MDR1))(NN (expression))(NN (regulation))(NN (cancer))(NN (drug))(NN (resistance))(NN (cSrc))(NN (beta-catenin))(NN (signaling))))) |ET|  |BS| 23:D12.776.091.249 69:G02.111.087.800 142:I01.880.604 1354:G07.690.773.984.395  |ES| 18:1 19:1 60:1 66:1 115:1 191:1 195:1 438:1 453:1 1094:1 2153:1 4702:1 4848:1  |EV| 
-1.68495580783240939126699231565  |BT| (NP (NP (NNS (METHODS)))(: (:))(S (NP (NP (NP (JJ (Stable))(JJ (transient))(NN (RNA))(NN (silencing))(NN (GAST))(NN (gene)))(VP (VBD (induced))(NP (NP (JJ (human))(NN (tumor))(NN (cell))(NN (mouse)))(VP (VBG (carrying))(NP (NP (JJ (heterozygous))(NN (Apc))(NN (mutation)))(PRN (-LRB- (-LRB-))(NP (NN (APCDelta14)))(-RRB- (-RRB-))))))))(, (,))(VP (VBP (overexpress))(NP (NN (progastrin)))))(VP (VBD (amidated))(NP (JJ (glycine-extended))(NN (gastrin)))))) |ET|  |BS| 3:C04.557.470.035.215.100 6:G05.360.340.024.340 8:C04 11:B01.050.150.900.649.865.635.505.500 18:G05.365.590 41:A11 42:G05.355.315.203.374 55:B01.050.150.900.649.801.400.112.400.400 156:G05.355.315.203.374.790 157:G05.380.383 168:E05.581 199:D06.472.317.413 200:D06.472.317.413 247:G01.374.676.530 1003:D12.125.481 1422:D13.444.735  |ES| 2:1 7:1 9:1 10:1 14:1 19:1 34:1 36:1 52:1 94:1 100:1 104:1 280:1 412:1 515:1 565:1 671:1 676:1 745:1 786:1 850:1 2513:1 5677:1 5678:1 5679:1 5680:1 5681:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (ADVP (RB (Finally)))(, (,))(NP (NN (PhIP)))(VP (VBD (appeared))(NP (NP (NP (JJ (carcinogenic))(NN (XPA)))(PRN (-LRB- (-LRB-))(: (-))(: (/))(: (-))(-RRB- (-RRB-))))(NN (mouse))(JJ (subtoxic))(NNS (dos))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 30:Z01.058.290.190.800 31:D08.811.520.224.800 279:D27.888.569.100  |ES| 2:1 10:1 14:1 19:1 45:1 52:1 1929:1 2641:1 2653:1 3346:1 3836:1 5416:1 5417:1  |EV| 
-0.038075308587622203049249947071075  |BT| (S (NP (NP (NNS (Genes)))(VP (VBG (encoding))(NP (NP (NN (DNA))(JJ (damage-inducible))(CD (45))(-LRB- (-LRB-))(NN (GADD45))(-RRB- (-RRB-))(NN (family))(NN (protein)))(, (,))(NP (NP (JJ (particular))(NN (GADD45g)))(PRN (-LRB- (-LRB-))(NP (NN (GADD45))(NN (gamma)))(-RRB- (-RRB-)))))))(VP (VBD (down-regulated))(NP (NP (NN (treatment)))(NP (CC (either))(NP (NN (PB))(NN (CF))(CD (4))(CD (13))(NN (week))))))) |ET|  |BS| 6:G05.360.340.024.340 7:D12.776 44:F01.829.263 52:E02 142:I01.880.604 325:Z01.058.290.100.140 351:A17.360 526:G05.355.180  |ES| 2:1 4:1 10:1 14:1 19:1 39:1 97:1 319:1 485:1 546:1 666:1 783:1 1100:1 1283:1 1532:1 2389:1 3495:1 3496:1 4177:1 4725:1 4737:1 4825:1 4826:1  |EV| 
-0.61443177387968717084731906652451  |BT| (S (PP (IN (In))(NP (NN (conclusion))))(, (,))(NP (NN (troglitazone)))(VP (VBD (attenuated))(NP (NN (Skp2))(NN (expression)))(, (,))(S (VP (ADVP (RB (thereby)))(NP (VBG (promoting))(NP (NN (p27))(-LRB- (-LRB-))(NN (Kip1))(-RRB- (-RRB-))(NN (accumulation))(JJ (human))(NN (hepatoma))(NN (cell)))))))) |ET|  |BS| 41:A11 55:B01.050.150.900.649.801.400.112.400.400 104:C04.557.470.200.025.255 338:D12.644.360.225.600 507:D12.776.157.743 515:C04.588.274.623  |ES| 2:1 10:1 14:1 19:1 36:1 94:1 115:1 244:1 808:1 881:1 1124:1 1125:1 1284:1 1785:1 2120:1 3896:1 4508:1 4896:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (NP (NP (ADJP (RB (Highly))(JJ (metastatic)))(JJ (hepatocellular))(NN (carcinoma)))(VP (VBD (induced))(NP (NP (JJ (male))(NN (F344))(NN (rat)))(NP (VBN (treated))(NN (N-nitrosomorpholine))(NN (combination))(NNS (hepatocarcinogens))))))(VP (VBP (show))(NP (JJ (high))(NN (incidence))(NN (p53))(NN (gene))(NN (mutation)))(PP (IN (along))(NP (JJ (altered))(NN (mRNA))(NN (expression))(JJ (tumor-related))(NN (gene)))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 8:C04 18:G05.365.590 52:E02 104:C04.557.470.200.025.255 111:D13.444.735.544 149:G05.360.340.024.340.364.875.890 155:G05.355.310 434:E05.318.308.985.525.375 590:B01.050.050.199.520.760.200  |ES| 9:1 12:1 19:1 34:1 115:1 178:1 303:1 304:1 325:1 337:1 412:1 429:1 530:1 693:1 849:1 1099:1 1402:1 1511:1 2666:1 2705:1 3185:1 3989:1 5432:1 5433:1  |EV| 
-2.1716049385377402813901426270604  |BT| (S (NP (JJ (Further))(NN (study)))(VP (VBD (revealed))(SBAR (S (NP (ADJP (NN (TFSC))(VBD (induced)))(NN (HCC))(NN (cell))(NN (apoptosis)))(VP (VBD (inhibited))(NP (NP (JJ (expressional))(NN (level))(NN (NF-kappaB))(JJ (responsive))(NN (gene)))(VP (VBN (transplanted))(NP (NN (tumor))(NN (tissue)))))))))) |ET|  |BS| 6:G05.360.340.024.340 8:C04 39:G04.299.139.160 41:A11 104:C04.557.470.200.025.255 122:C14.280.383 210:D12.776.260.600 1345:A01.941 1346:A01.941  |ES| 7:1 9:1 19:1 89:1 94:1 131:1 249:1 272:1 275:1 330:1 365:1 412:1 441:1 714:1 4799:1 4800:1 4801:1 4802:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (ADVP (RB (Furthermore)))(, (,))(NP (NP (JJ (stress-associated))(NN (hormone)))(, (,))(NP (NN (isoproterenol)))(, (,)))(VP (MD (could))(VP (VP (VB (increase))(NP (NN (expression))(NN (level))(`` (``))(NN (stem))('' (''))))(: (-))(S (NP (NP (JJ (related))(NN (protein)))(, (,))(NP (NN (CD44)))(, (,))(NP (NNP (Nanog)))(, (,))(NP (NN (Rex-1)))(, (,)))(VP (VBP (induce))(NP (NN (chemoresistance))(JJ (gastric))(NN (cancer))(NN (cell)))))))) |ET|  |BS| 7:D12.776 41:A11 161:D06.472 309:A18.024.937 1474:D02.033.100.291.439  |ES| 2:1 4:1 18:1 19:1 40:1 86:1 94:1 115:1 182:1 243:1 249:1 334:1 542:1 908:1 1106:1 1282:1 1581:1 3268:1 3269:1 5421:1 5422:1 5423:1 5424:1  |EV| 
-1.870860856084146206512741628103  |BT| (S (NP (NNP (UNLABELLED))(: (:)))(S (VP (TO (To))(VP (VB (evaluate))(NP (NN (possibility))(JJ (radionuclide))(NN (gene))(NN (therapy))(NN (imaging))(JJ (hepatocellular))(NN (carcinoma))(NN (cancer))))))(, (,))(VP (VBD (investigated))(NP (NP (NP (NN (iodine))(NN (accumulation))(JJ (human))(JJ (hepatocellular))(NN (carcinoma))(NN (cell))(NN (line)))(, (,))(NP (NN (SK-Hep1))))(, (,))(NP (NP (NN (transfer))(JJ (human))(NN (sodium))(NN (iodide))(NN (symporter)))(PRN (-LRB- (-LRB-))(NP (NN (hNIS)))(-RRB- (-RRB-))))(NP (NN (gene)))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 38:Z01.058.290.120.180 40:Z01.542.248.700 55:B01.050.150.900.649.801.400.112.400.400 94:A11.251.210 104:C04.557.470.200.025.255 225:E05.337 265:C04.557.470.200 967:D01.248.497.158.490 1017:E01.370.350 1274:D01.268.380.400 1275:D01.496.749  |ES| 2:1 9:1 10:1 14:1 18:1 19:1 36:1 94:1 104:1 130:1 264:1 303:1 304:1 343:1 403:1 407:1 828:1 890:1 1644:1 2120:1 2266:1 3561:1 4513:1 4514:1 4515:1 4516:1 4517:1 4518:1  |EV| 
-0.99720191184986184396166208898649  |BT| (NP (NP (NN (Calcium))(NN (chloride)))(, (,))(NP (NN (DFMO))(NN (piroxicam)))(NP (NP (VBD (increased))(NN (protein))(NN (mRNA))(NN (level))(NN (p16)))(PP (IN (along))(NP (NN (sulindac)))))(NP (VBD (increased))(NN (protein))(NN (level))(NN (p27)))(, (,))(NP (NN (mRNA)))) |ET|  |BS| 7:D12.776 111:D13.444.735.544 203:G05.360.340.024.340.375.249.375 251:D02.455.426.559.847.486.875 1294:D01.146.300 1295:D12.125.068.665.340 1296:D02.886.665.500  |ES| 2:1 4:1 19:1 47:1 249:1 325:1 869:1 1124:1 1313:1 2666:1 2788:1 4612:1 4613:1 4614:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (NP (JJ (Consistent))(NN (finding))(, (,))(NN (treatment))(NP (NP (NN (protein))(NN (kinase))(NN (A)))(PRN (-LRB- (-LRB-))(NP (NN (PKA)))(-RRB- (-RRB-))))(NN (inhibitor)))(VP (VBD (decreased))(NP (NN (MMP2))(NN (MMP9))(NN (expression))(NN (level))(JJ (ADCY3-overexpressing))(NN (cell))))) |ET|  |BS| 41:A11 52:E02 586:D08.811.277.656.300.480.205.360 1417:D08.811.277.656.300.480.205.352  |ES| 2:1 4:1 10:1 14:1 19:1 69:1 94:1 115:1 202:1 249:1 380:1 470:1 546:1 927:1 3395:1 5408:1 5409:1 5410:1 5411:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (ADVP (RB (Finally)))(, (,))(VP (VBP (demonstrate))(NP (NP (JJ (NSAID-mediated))(JJ (nucleolar))(NN (translocation))(NN (RelA)))(VP (VBN (associated))(NP (NP (NN (downregulation))(JJ (NF-kappaB-driven))(NN (transcription))(NN (NF-kappaB))(NN (target))(NN (gene)))(, (,))(NP (NN (ICAM-1)))))))) |ET|  |BS| 6:G05.360.340.024.340 66:F01.658.293 85:G02.111.087.225 209:G02.111.087.847 210:D12.776.260.600 463:C23.550.210.870 796:D27.505.696.663.850.014.040.500 1325:D12.776.395.550.200.450  |ES| 2:1 9:1 19:1 160:1 169:1 250:1 487:1 502:1 595:1 714:1 1618:1 1929:1 4732:1 5418:1 5419:1 5420:1  |EV| 
-0.18996912076170247019035741686821  |BT| (S (NP (NP (NNS (Rats)))(VP (VBN (fed))(NP (JJ (high-dose))(NN (CP-31398))(NN (combination))(JJ (low-dose))(NN (CP-31398))(NN (celecoxib)))))(VP (VBD (showed))(NP (NP (NP (NP (NP (JJ (considerable))(NN (enhancement))(NN (p53))(NN (p21)))(PRN (-LRB- (-LRB-))(NP (NN (WAF1/CIP)))(-RRB- (-RRB-))))(NN (expression)))(, (,))(NP (NN (apoptosis)))(, (,)))(VP (VBN (reduced))(NP (NN (tumor))(NN (cell))(NN (proliferation))(JJ (colonic))(NN (tumor))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 8:C04 39:G04.299.139.160 51:C04.588.274.476.411.307.180 183:G04.299.233.750 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 663:C16.320.565.398.500.330.500 684:D02.065.884.247  |ES| 2:1 7:1 10:1 12:1 14:1 19:1 89:1 94:1 115:1 132:1 299:1 452:1 530:1 677:1 1135:1 2278:1 2426:1 2807:1 3047:1 3049:1 3664:1 5117:1 5118:1 5119:1  |EV| 
-1.117989540576900253654457628727  |BT| (NP (NP (NP (NNP (Grifolin)))(, (,))(NP (JJ (potent))(NN (antitumour))(JJ (natural))(NN (product)))(VP (VBZ (upregulates))(NP (NP (JJ (death-associated))(NN (protein))(NN (kinase))(CD (1))(NN (DAPK1)))(PP (IN (via))(NP (NN (p53))(JJ (nasopharyngeal))(NN (carcinoma))(NN (cell)))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 41:A11 793:D20.215 1285:D08.811.913.696.620.682.700.125.387  |ES| 2:1 4:1 12:1 19:1 22:1 94:1 98:1 304:1 470:1 596:1 675:1 1178:1 2153:1 2333:1 4572:1 4849:1 4850:1 4851:1  |EV| 
-3.2009816039862366565671436546836  |BT| (S (NP (NN (Isochaihulactone)))(VP (VBD (increased))(NP (NN (EGR-1))(NN (NAG-1))(NN (mRNA))(NN (protein))(NN (expression))))) |ET|  |BS| 7:D12.776 111:D13.444.735.544 580:D12.776.260.158.500  |ES| 4:1 19:1 47:1 115:1 325:1 1662:1 3874:1 4962:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (NP (NN (Induction))(NN (apoptosis))(NN (pectenotoxin-2)))(VP (VBD (mediated))(NP (NP (NP (NN (induction))(NN (DR4/DR5)))(, (,))(NP (NN (Egr-1))(NN (NAG-1))))(, (,))(NP (NN (activation))(NN (caspase))(NN (modulation))(NN (Bcl-2))(NN (family))(JJ (p53-deficient))(NN (Hep3B))(JJ (hepatocellular))(NN (carcinoma))(NN (cell)))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 39:G04.299.139.160 41:A11 44:F01.829.263 54:G05.360.340.024.340.375.500.791.150 104:C04.557.470.200.025.255 580:D12.776.260.158.500 1367:D08.811.277.656.262.500.126  |ES| 2:1 19:1 89:1 94:1 97:1 158:1 225:1 303:1 304:1 437:1 736:1 1662:1 1945:1 2020:1 4498:1 4502:1 4561:1 4796:1 5236:1 5445:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (NP (PRP$ (Our))(NN (study)))(ADVP (RB (also)))(VP (VBP (demonstrate))(NP (VBN (utilized))(NN (DEN/PB))(NN (protocol))(NNP (WT))(NN (C57BL/6))(NN (mouse))(JJ (select))(NN (beta-catenin))(NN (gene))(NN (mutation))(NN (hepatocarcinogenesis))))) |ET|  |BS| 18:G05.365.590 23:D12.776.091.249 593:B01.050.050.199.520.520.420  |ES| 5:1 9:1 19:1 34:1 52:1 60:1 131:1 502:1 658:1 900:1 1182:1 1995:1 2192:1 3216:1 4183:1 5498:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (NP (NP (NN (DNA))(NN (binding))(NN (activity))(JJ (nuclear))(NN (factor))(NN (kappa))(NN (B)))(PRN (-LRB- (-LRB-))(NP (NN (NF-kappaB)))(-RRB- (-RRB-))))(VP (VBZ (transactivates))(NP (NP (NP (NN (miR-155))(NN (gene)))(ADJP (ADVP (RB (significantly)))(PRN (-LRB- (-LRB-))(S (NP (NN (P)))(VP (JJ (=))(NP (CD (0.002)))))(-RRB- (-RRB-))))(JJ (elevated))(NN (liver))(JJ (nuclear))(NN (extract))(NN (mouse)))(VBN (fed))(NNP (CDAA))(NN (diet))))) |ET|  |BS| 6:G05.360.340.024.340 11:B01.050.150.900.649.865.635.505.500 198:D13.444.308 210:D12.776.260.600 595:G07.203.650.240 596:E02.642.249 663:C16.320.565.398.500.330.500 1473:D20.777.351  |ES| 9:1 10:1 14:1 19:1 52:1 124:1 185:1 311:1 399:1 581:1 666:1 714:1 756:1 763:1 836:1 1254:1 1256:1 1487:1 1911:1 2191:1 2426:1 2496:1 3184:1 3750:1 5066:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (NP (NN (Induction))(NN (SPARC)))(VP (VBD (demonstrated))(NP (NN (treatment))(JJ (demethylating))(NN (agent))(NN (5Aza-dC))(CD (5))(CD (7))(NN (cell))(NN (line))))) |ET|  |BS| 37:D12.776.157.125.715 94:A11.251.210 775:E02.760.058  |ES| 19:1 82:1 94:1 264:1 546:1 578:1 728:1 988:1 1175:1 2020:1 5446:1 5447:1  |EV| 
-0.99124121472925708076218143105507  |BT| (S (NP (JJ (Gefitinib))(NN (treatment)))(VP (VBD (diminished))(NP (NP (ADJP (NP (NN (phosphorylation))(NN (ErbB-3)))(JJR (>)))(NN (EGFR)))(JJR (>))(NN (HER2/neu))(NN (signal))(NN (transducer))(NN (activator))(NN (transcription))(JJ (dose-dependent))(NN (fashion))))) |ET|  |BS| 52:E02 63:G05.360.340.024.340.375.500.791.295.305 209:G02.111.087.847 250:E07.305.812 972:G02.111.087.677 1350:G05.360.340.024.340.375.500.791.295  |ES| 19:1 187:1 487:1 546:1 859:1 860:1 861:1 901:1 1466:1 2824:1 3024:1 3426:1 4156:1 4754:1 4818:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (S (S (ADVP (RB (Additionally)))(, (,))(NP (NN (co-treatment))(NN (RV))(NN (erlotinib)))(VP (VBD (repressed))(NP (NP (NN (expression))(JJ (anti-apoptosis))(NN (protein)))(, (,))(NP (NN (survivin))(NN (Mcl-1)))))(, (,)))(IN (whereas))(NP (VBN (promoted))(NN (p53))(NN (PUMA))(NN (expression))(NN (caspase))(CD (3))(NN (activity))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 52:E02 906:D08.811.277.656.262.500.126.350.300 1042:Z01.107.757.284 1467:B01.050.150.900.649.147.354.630 1468:E01.370.386.700.485.750.275.650 1469:D12.644.360.075  |ES| 2:1 4:1 12:1 19:1 115:1 372:1 399:1 466:1 862:1 1912:1 2229:1 2342:1 4068:1 4796:1 5312:1 5389:1 5390:1 5391:1 5392:1  |EV| 
-3.2009816039862366565671436546836  |BT| (NP (NP (PP (IN (In))(NP (NP (NN (tumor))(NN (mouse))(VBN (treated))(NN (DEN)))(ADVP (RB (alone)))))(, (,))(NP (NP (NP (NN (prevalence))(NN (Ha-ras))(NN (mutation)))(NP (ADJP (QP (RB (approximately))(CD (30)))(NN (%)))(PRN (-LRB- (-LRB-))(NP (CD (6/20)))(-RRB- (-RRB-)))))(, (,))(NP (NP (NN (beta-catenin))(NN (mutation)))(PRN (-LRB- (-LRB-))(NP (CD (0/13)))(-RRB- (-RRB-))))(NP (JJ (detectable))(NN (tumor))(NN (treatment))(NN (group)))))) |ET|  |BS| 1:G05.360.340.024.340.375.500.791.550 8:C04 11:B01.050.150.900.649.865.635.505.500 18:G05.365.590 23:D12.776.091.249 52:E02 60:E05.318.308.985.525.750 216:Z01.107.084.900.425 829:M01.686  |ES| 2:1 7:1 10:1 14:1 19:1 34:1 52:1 60:1 179:1 241:1 244:1 369:1 546:1 747:1 1099:1 1520:1 1843:1 1875:1 2300:1 4933:1 4934:1 4935:1  |EV| 
-3.2003509498909892272422439418733  |BT| (S (ADVP (RB (However)))(, (,))(NP (NP (NNS (pretreatments))(NP (NP (JJ (selective))(JJ (mitogen-activated))(NN (protein))(NN (kinase)))(PRN (-LRB- (-LRB-))(NP (NN (MAPK)))(-RRB- (-RRB-))))(NN (inhibitor)))(, (,))(NP (NP (NP (NP (NN (SB203580)))(PRN (-LRB- (-LRB-))(NP (NN (p38))(NN (inhibitor)))(-RRB- (-RRB-))))(NN (PD0325901)))(PRN (-LRB- (-LRB-))(NP (NN (ERK1/2))(NN (inhibitor)))(-RRB- (-RRB-))))(, (,)))(ADVP (RB (significantly)))(VP (VBD (suppressed))(NP (NN (activation))(NN (EGCG))(NN (BTG2))(NN (expression))))) |ET|  |BS| 116:D08.811.913.696.620.682.700.567.249.750 478:D08.811.913.696.620.682.700.567  |ES| 2:1 4:1 10:1 14:1 19:1 115:1 124:1 225:1 307:1 380:1 433:1 470:1 809:1 1666:1 1749:1 2525:1 3295:1 4594:1 4883:1 4884:1 4885:1 4886:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (SBAR (IN (Of))(S (NP (CD (two))(NN (gene)))(VP (VBP (encode))(NP (NP (NN (methionine))(NN (adenosyltransferase)))(PRN (-LRB- (-LRB-))(NP (NN (MAT1Aand))(NN (MAT2A)))(-RRB- (-RRB-)))))))(, (,))(NP (NN (MAT1A)))(ADVP (RB (mainly)))(VP (VBD (expressed))(NP (JJ (adult))(NN (liver)))(SBAR (IN (whereas))(S (NP (NN (MAT2A)))(VP (VBD (expressed))(NP (JJ (extrahepatic))(NN (tissue)))))))) |ET|  |BS| 6:G05.360.340.024.340 98:A10 119:M01.060.116 242:A03.620 574:D08.811.913.225.650  |ES| 2:1 6:1 9:1 10:1 14:1 19:1 272:1 355:1 372:1 836:1 933:1 1429:1 1792:1 2050:1 2051:1 5485:1 5486:1 5487:1 5488:1 5489:1  |EV| 
-3.1036248270433084428532310994342  |BT| (S (PP (IN (In))(NP (NN (study))))(, (,))(VP (VBD (demonstrated))(NP (NP (JJ (simvastatin-induced))(NN (G0/G1))(NN (arrest)))(VP (VBG (inducing))(NP (NN (p21))(NN (p27))(NN (accumulation))(NN (HepG2))(NN (Hep3B))(NN (cell))))))) |ET|  |BS| 41:A11 754:D02.455.426.559.847.638.400.900  |ES| 2:1 19:1 94:1 131:1 244:1 602:1 1124:1 1135:1 1175:1 1864:1 2120:1 3481:1 4502:1 5665:1 5666:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (NP (NN (IR-5))(NN (bear))(JJ (novel))(NN (point))(NN (mutation))(NN (HER2/neu)))(VP (VP (VBZ (corresponds))(SBAR (S (NP (NN (L726I))(JJ (ATP-binding))(NN (pocket)))(VP (VBP (correlate))(NP (NN (log))(NN (decrease))(NN (sensitivity))(NN (gefitinib)))))))(, (,))(NP (NP (VBD (increased))(NN (heterodimerization))(NN (EGFR))(NN (HER3)))(, (,))(NP (JJ (impaired))(NN (down-regulation)))))) |ET|  |BS| 63:G05.360.340.024.340.375.500.791.295.305 85:G02.111.087.225 259:D12.776.395.240.150.500 438:G05.365.590.675 455:B01.050.150.900.649.147.890 1064:Z01.252.245.500.350 1065:D01.268.556.401  |ES| 2:1 19:1 34:1 47:1 187:1 257:1 295:1 607:1 891:1 901:1 1740:1 2003:1 2121:1 3310:1 3505:1 4281:1 4955:1 4956:1 4957:1 4958:1 4959:1 4960:1 4961:1  |EV| 
-3.2009816039862366565671436546836  |BT| (S (NP (JJ (Isochaihulactone-inducible))(NN (gene)))(VP (VBD (included))(S (NP (NP (JJ (early))(NN (growth))(NN (response))(NN (gene-1)))(PRN (-LRB- (-LRB-))(NP (NN (EGR-1)))(-RRB- (-RRB-))))(NP (NP (JJ (nonsteroidal))(JJ (anti-inflammatory))(JJ (drug-activated))(NN (gene)))(PRN (-LRB- (-LRB-))(NP (NN (NAG-1)))(-RRB- (-RRB-))))))) |ET|  |BS| 6:G05.360.340.024.340 45:G07.700.320.249 796:D27.505.696.663.850.014.040.500  |ES| 9:1 10:1 14:1 19:1 102:1 494:1 1128:1 1528:1 1662:1 1859:1 2795:1 3046:1 3874:1 4977:1 4978:1  |EV| 
3.2009816039862366565671436546836  |BT| (NP (NP (NP (JJ (Genotype-phenotype))(NN (correlation))(JJ (murine))(NN (Apc))(NN (mutation)))(: (:))(NP (NN (difference))(NN (enterocyte))(NN (migration))(NN (response))(NN (sulindac))))) |ET|  |BS| 3:C04.557.470.035.215.100 11:B01.050.150.900.649.865.635.505.500 18:G05.365.590 251:D02.455.426.559.847.486.875 1475:A03.556.124.369.290 1476:E05.393.385  |ES| 19:1 34:1 104:1 280:1 494:1 514:1 627:1 869:1 1674:1 3544:1 5427:1 5428:1  |EV| 
-3.0702721614586607756791636347771  |BT| (S (ADVP (RB (Moreover)))(, (,))(NP (NN (MCC-555)))(VP (VBD (increased))(NP (JJ (transcriptional))(NN (activity))(JJ (human))(NN (mouse))(NN (MUC2))(NN (promoter))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 209:G02.111.087.847 1390:I03  |ES| 2:1 19:1 36:1 47:1 52:1 83:1 212:1 399:1 559:1 622:1 5043:1  |EV| 
-1.6239593978506121629834524355829  |BT| (S (NP (NN (AIMS/METHODS)))(: (:))(NP (PRP (We)))(VP (VBD (evaluated))(NP (NP (FW (vivo))(NN (effect))(JJ (intraperitoneal))(NN (injection))(NN (Ras))(NN (inhibitor))(NN (S-trans)))(, (,))(NP (NP (NP (JJ (trans-farnesylthiosalicyclic))(NN (acid)))(PRN (-LRB- (-LRB-))(NP (NN (FTS)))(-RRB- (-RRB-))))(S (NP (NN (Ras))(NN (activation))(NN (development))(JJ (preneoplastic))(NN (liver))(NN (lesion))(NN (rat)))(VP (VBG (receiving))(NP (NP (NP (JJ (weekly))(NN (diethylnitrosamine)))(PRN (-LRB- (-LRB-))(NP (NN (DEN)))(-RRB- (-RRB-))))(NN (injection))(NNS (16weeks))))))))) |ET|  |BS| 1:G05.360.340.024.340.375.500.791.550 168:E05.581 225:E05.337 226:E02.319.267.530 242:A03.620 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 554:D02.654.442.200 917:E02.319.267.530.490 1062:D01.029  |ES| 2:1 10:1 14:1 19:1 35:1 75:1 104:1 225:1 378:1 380:1 548:1 780:1 785:1 836:1 843:1 849:1 1131:1 1275:1 1438:1 1775:1 1875:1 1952:1 3230:1 4076:1 4548:1 4549:1 4550:1 4551:1 4552:1  |EV| 
-3.2009816039862366565671436546836  |BT| (S (NP (NN (CONCLUSION))(: (:)))(NP (PRP$ (Our))(NN (finding)))(VP (VBP (reveal))(NP (NN (p53))(NN (increase))(JJ (human))(NN (glioblastoma))(NN (sensitivity))(NN (celecoxib))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 55:B01.050.150.900.649.801.400.112.400.400 592:C04.557.465.625.600.380.080.335 684:D02.065.884.247  |ES| 12:1 19:1 36:1 40:1 104:1 607:1 658:1 927:1 1670:1 1882:1 2186:1 2807:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (NP (PRP$ (Our))(NN (model)))(VP (VBZ (predicts))(NP (NP (NP (NN (5FU))(NN (sensitivity))(NN (tumor)))(VP (VBN (modified))(S (NP (NN (aneuploidy)))(VP (VBG (producing))(NP (NN (copy))(NN (number))(NN (change))(NN (TS))(NN (allele))(CD (one))(NN (following)))))))(: (:))(NP (NP (NN (LOH)))(, (,))(NP (NN (amplification)))(, (,))(, (,))(NP (VBN (presented))(, (,))(NP (NN (copy))(NN (number))(NN (change))(JJ (due))(NN (polysomy)))))))) |ET|  |BS| 8:C04 77:G05.360.340.024.340.030 154:Z01.058.266.887 290:G05.365.590.029.530 560:D03.383.742.698.875.404 1494:C23.550.210.050  |ES| 2:1 7:1 19:1 72:1 104:1 200:1 230:1 509:1 607:1 646:1 658:1 921:1 963:1 1004:1 1010:1 1751:1 2335:1 2851:1 3510:1 5493:1 5494:1 5495:1 5496:1 5497:1  |EV| 
3.2009816039862366565671436546836  |BT| (FRAG (NP (NP (NP (NP (RB (Early))(NN (detection)))(JJ (2-amino-1-methyl-6-phenylimidazo))(-LRB- (-LRB-))(JJ (4,5-b))(-RRB- (-RRB-))(NN (pyridine))(-LRB- (-LRB-))(NN (PhIP))(-RRB- (-RRB-))(: (-)))(VBN (induced))(NN (mutation)))(PP (IN (within))(NP (NN (Apc))(NN (gene))(NN (rat))(NN (colon)))))) |ET|  |BS| 18:G05.365.590 21:G05.360.340.024.340.375.249.050 46:A03.556.124.526.356 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 494:E01.390 744:D03.383.725  |ES| 9:1 10:1 14:1 19:1 34:1 113:1 280:1 409:1 849:1 1023:1 2122:1 2638:1 2639:1 2640:1 2641:1 4135:1  |EV| 
-3.2009816039862366565671436546836  |BT| (NP (NP (NP (NP (NNP (Ornithine))(NN (decarboxylase)))(PRN (-LRB- (-LRB-))(NP (NN (ODC)))(-RRB- (-RRB-))))(, (,))(NP (JJ (first))(NN (enzyme))(NN (polyamine))(NN (synthesis)))(, (,))(NP (JJ (transcriptional))(NN (target))(NN (c-myc))(NN (modifier))(JJ (APC-dependent))(NN (tumorigenesis))))) |ET|  |BS| 3:C04.557.470.035.215.100 20:G03.495 32:C04.697.098.500 33:C04.697.098 209:G02.111.087.847 730:D08.811 1313:D02.092.782 1398:D08.811.520.224.125.425  |ES| 2:1 10:1 14:1 19:1 78:1 160:1 455:1 559:1 816:1 2388:1 2697:1 3436:1 3819:1 4672:1 5076:1 5077:1 5078:1  |EV| 
-3.2009816039862366565671436546836  |BT| (S (NP (NN (IR-5))(NN (bear))(JJ (novel))(NN (point))(NN (mutation))(NN (HER2/neu)))(VP (VP (VBZ (corresponds))(SBAR (S (NP (NN (L726I))(JJ (ATP-binding))(NN (pocket)))(VP (VBP (correlate))(NP (NN (log))(NN (decrease))(NN (sensitivity))(NN (gefitinib)))))))(, (,))(NP (NP (VBD (increased))(NN (heterodimerization))(NN (EGFR))(NN (HER3)))(, (,))(NP (JJ (impaired))(NN (down-regulation)))))) |ET|  |BS| 63:G05.360.340.024.340.375.500.791.295.305 85:G02.111.087.225 259:D12.776.395.240.150.500 438:G05.365.590.675 455:B01.050.150.900.649.147.890 1064:Z01.252.245.500.350 1065:D01.268.556.401  |ES| 2:1 19:1 34:1 47:1 187:1 257:1 295:1 607:1 891:1 901:1 1740:1 2003:1 2121:1 3310:1 3505:1 4281:1 4955:1 4956:1 4957:1 4958:1 4959:1 4960:1 4961:1  |EV| 
-2.3333895758798917086096480488777  |BT| (S (NP (CD (1,25))(NN (D)))(VP (VBD (inhibited))(SBAR (S (NP (NN (MYC))(NN (gene))(NN (expression)))(VP (VBD (accelerated))(NP (NN (protein))(NN (turnover)))))))) |ET|  |BS| 7:D12.776 122:C14.280.383 155:G05.355.310 185:G05.360.340.024.340.375.500.791.420 186:G05.360.340.024.340.375.500.791.420 665:N04.452.677.680  |ES| 4:1 9:1 19:1 115:1 365:1 472:1 1391:1 2424:1 4529:1  |EV| 
3.2009816039862366565671436546836  |BT| (FRAG (PP (IN (In))(NP (NN (study))))(, (,))(NP (VBN (examined))(NN (role))(NN (Ras))(NN (Cox-2))(NN (inhibition))(NN (UDCA)))) |ET|  |BS| 1:G05.360.340.024.340.375.500.791.550 15:F01.829.316.616 43:F01.145.544 737:D04.808.105.225.272.962  |ES| 2:1 19:1 31:1 62:1 103:1 131:1 244:1 324:1 1775:1 2631:1  |EV| 
-2.1993714318193724466254934668541  |BT| (NP (NP (NP (NN (Relationship))(NN (CYP1A))(NN (induction))(NN (indole-3-carbinol))(NN (flutamide))(NN (liver)))(JJ (tumor-promoting))(JJ (potential))(NN (rat)))) |ET|  |BS| 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 515:C04.588.274.623 1172:D02.065.199.420  |ES| 19:1 736:1 827:1 836:1 849:1 3647:1 3776:1 4057:1 5121:1 5122:1  |EV| 
3.2009816039862366565671436546836  |BT| (S (PP (IN (In))(NP (NN (summary))))(, (,))(NP (VBN (shown))(JJ (first))(NN (time))(NN (UDCA)))(VP (VBD (suppressed))(SBAR (S (NP (NN (development))(NN (tumor))(NN (Ras))(NN (mutation)))(VP (VBD (blocked))(NP (NN (activation))(NNP (WT))(NN (Ras)))))))) |ET|  |BS| 1:G05.360.340.024.340.375.500.791.550 8:C04 18:G05.365.590 322:G01.910 737:D04.808.105.225.272.962  |ES| 2:1 7:1 19:1 34:1 35:1 225:1 237:1 244:1 307:1 490:1 816:1 1081:1 1775:1 1995:1 2631:1 2777:1  |EV| 
3.2009816039862366565671436546836  |BT| (NP (NP (DT (Both))(NP (NNP (BaA))(NNPS (MeBaAs))(JJ (similar))(NN (effect))(NN (expression))(NN (cytochrome))(NN (P450))(NN (1B1))(JJ (aldo-keto))(NN (reductase))(NN (1C9))(NN (rat))(NN (liver))(JJ (epithelial))(NN (WB-F344))(NN (cell))))) |ET|  |BS| 75:A11.436 242:A03.620 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 590:B01.050.050.199.520.760.200  |ES| 19:1 75:1 94:1 96:1 115:1 127:1 332:1 836:1 849:1 2549:1 3276:1 3788:1 4678:1 5394:1 5395:1 5396:1 5397:1 5398:1  |EV| 
-3.2009816039862366565671436546836  |BT| (S (PP (IN (In))(NP (NN (conclusion))))(, (,))(VP (VBD (found))(NP (NP (NN (U0126))(JJ (atypical))(NN (PXR))(NN (ligand)))(PP (IN (via))(NP (NP (NP (NP (JJ (direct)))(PRN (-LRB- (-LRB-))(NP (NN (binding))(NN (activation))(NN (PXR)))(-RRB- (-RRB-))))(ADJP (ADJP (JJ (indirect)))(PRN (-LRB- (-LRB-))(NP (NN (SHP))(NN (dowregulation)))(-RRB- (-RRB-)))))(NN (mechanism)))))(PP (ADVP (RB (selectively)))(VBZ (restores))(NP (NN (CYP3A))(NN (gene))(NN (HepG2))(NN (cell)))))) |ET|  |BS| 6:G05.360.340.024.340 170:D27.720.470.480 1015:A11.251.860.180.432  |ES| 2:1 9:1 10:1 14:1 19:1 37:1 94:1 162:1 225:1 244:1 596:1 1284:1 1487:1 1835:1 1891:1 2382:1 3481:1 3523:1 4897:1 4898:1 4899:1 4900:1 4901:1 4902:1 4903:1  |EV| 
3.2009816039862366565671436546836  |BT| (NP (NP (JJ (Altered))(NN (expression))(NN (c-myc)))(, (,))(NP (NN (p16))(NN (p27))(NN (rat))(NN (colon))(NN (tumor))(NN (reversal))(JJ (short-term))(NN (treatment))(JJ (chemopreventive))(NN (agent)))) |ET|  |BS| 51:C04.588.274.476.411.307.180 52:E02 203:G05.360.340.024.340.375.249.375 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 833:D27.505.696.706.018 849:G08.686.785.760.769.490.500  |ES| 2:1 7:1 19:1 113:1 115:1 455:1 546:1 728:1 849:1 971:1 1124:1 1313:1 1946:1 3022:1 3770:1  |EV| 
-0.26505289132711595811997540295124  |BT| (S (ADVP (RB (Here)))(, (,))(NP (NN (report))(NN (NaB)))(ADVP (RB (specifically)))(VP (VBZ (represses))(NP (NP (NP (NP (NN (expression))(NN (MUC2))(NN (gene)))(, (,))(NP (NN (differentiation))(NN (marker))(JJ (secretory))(NN (goblet))(NN (cell))(NN (lineage)))(, (,))(NP (NN (forskolin)))(: (-)))(NP (NN (12-O-tetradecanoylphorbol))(JJ (13-acetate-induced))(NN (HT29))(NN (cell))))(, (,))(NP (NN (Cl))(CD (.16))(NN (E))(NN (cell)))(, (,))(NP (JJ (clonal))(JJ (derivative))(NN (HT29))(NN (cell))))(VP (ADVP (RB (spontaneously)))(VBZ (differentiates))(NP (JJ (goblet))(NN (cell)))))) |ET|  |BS| 41:A11 74:G04.299.151 155:G05.355.310 158:D23.101 301:A11.251.353 792:A11.251.210.190.475 1361:D02.455.849.291.500.510.850 1362:A03.556.124.369.320 1363:D02.455.849.291.300  |ES| 2:1 9:1 19:1 94:1 115:1 212:1 215:1 347:1 400:1 417:1 534:1 643:1 1069:1 1262:1 1279:1 1506:1 2473:1 2813:1 3017:1 3759:1 4866:1 4867:1 4868:1 4869:1 4870:1  |EV| 
-3.2009816039862366565671436546836  |BT| (S (NP (JJ (Colonic))(NN (adenocarcinoma)))(ADVP (RB (rapidly)))(VP (VBD (induced))(NP (NP (JJ (combined))(NP (NN (treatment))(JJ (2-amino-1-methyl-6-phenylimidazo))(-LRB- (-LSB-))(JJ (4,5-b))(-RRB- (-RSB-))(NN (pyridine))(NN (dextran))(NN (sodium))(NN (sulfate))(JJ (male))(NN (ICR))(NN (mouse))(NN (posse))(NN (beta-catenin))(NN (gene))(NN (mutation)))(NN (increase))(NN (immunoreactivity))(NN (beta-catenin)))(, (,))(NP (NN (cyclooxygenase-2))(JJ (inducible))(JJ (nitric))(NN (oxide))(NN (synthase)))))) |ET|  |BS| 18:G05.365.590 22:D08.811.682.664.500.772.500 23:D12.776.091.249 24:D08.811.600.720.750 46:A03.556.124.526.356 84:C04.557.470.200.025 131:D09.698.365.272.300 618:E02.186 744:D03.383.725 1316:B01.050.050.199.520.520.510  |ES| 2:1 9:1 19:1 34:1 40:1 52:1 60:1 61:1 63:1 64:1 65:1 66:1 164:1 255:1 406:1 407:1 412:1 546:1 1373:1 1378:1 1402:1 2638:1 2639:1 2640:1 3048:1 3300:1 3424:1 4675:1 4676:1 4677:1  |EV| 
-0.9299881391623330273432657122612  |BT| (S (NNS (Changes))(NP (JJ (circadian))(NN (cycle))(NN (gene)))(: (-))(S (NP (RB (primarily))(NP (NN (transcription))(NN (factor)))(: (-)))(VP (VBD (showed))(SBAR (S (NP (ADJP (NP (JJ (strong))(JJ (concentration-related))(NN (response)))(JJR (higher)))(NN (concentration)))(-LRB- (-LRB-))(S (NP (NP (NN (Arntl)))(, (,))(NP (NN (Npas2)))(, (,))(NP (NN (Clock))))(VP (VBD (down-regulated))))(: (;))(PRN (NP (NP (NN (Cry2)))(, (,))(NP (NN (Wee1)))(, (,))(NP (NN (Bhlhe40)))(, (,))(NP (NN (Per3)))(, (,))(NP (NN (Nr1d1)))(, (,))(NP (NN (Nr1d2))(NN (Dbp))))(-RRB- (-RRB-))(S (VP (VBD (up-regulated))(NP (JJ (similar))(NN (directionality))(NN (tissue))))))))))) |ET|  |BS| 98:A10 142:I01.880.604 150:Z01.542.248.960 166:D12.776.930 351:A17.360 776:G01.910.645 905:F02.830.104.214  |ES| 2:1 9:1 10:1 14:1 19:1 132:1 170:1 185:1 217:1 272:1 332:1 487:1 494:1 601:1 1283:1 1301:1 1970:1 2691:1 3189:1 3578:1 5337:1 5583:1 5584:1 5585:1 5586:1 5587:1 5588:1 5589:1 5590:1 5591:1 5592:1 5593:1 5594:1 5595:1  |EV| 
3.2009816039862366565671436546836  |BT| (NP (NP (NP (NP (NN (Histogenesis))(NN (role))(NN (p53))(NN (K-ras))(NN (mutation))(NN (hepatocarcinogenesis))(NN (glyceryl))(NN (trinitrate)))(PRN (-LRB- (-LRB-))(NP (NN (nitroglycerin)))(-RRB- (-RRB-))))(JJ (male))(NN (F344))(NN (rat)))) |ET|  |BS| 1:G05.360.340.024.340.375.500.791.550 2:G05.360.340.024.340.375.249.385 15:F01.829.316.616 18:G05.365.590 590:B01.050.050.199.520.760.200 1478:D02.033.800.421.560  |ES| 10:1 12:1 14:1 19:1 31:1 34:1 849:1 900:1 1121:1 1402:1 3185:1 5434:1 5435:1 5436:1 5437:1  |EV| 
3.2009816039862366565671436546836  |BT| (NP (NP (NP (NN (Mutation))(NN (analysis))(NN (XPA)))(PRN (-LRB- (-LRB-))(: (-))(: (/))(: (-))(-RRB- (-RRB-))))(NP (NP (NN (mouse))(VBG (carrying))(NN (lacZ))(NN (reporter))(NN (gene)))(, (,))(S (VP (VBD (indicated))(SBAR (S (NP (VBN (observed))(NN (toxicity))(NN (PhIP)))(VP (MD (might))(VP (VBD (caused))(NP (JJ (genotoxic))(NN (effect))(JJ (small))(NN (intestine))))))))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 18:G05.365.590 100:G05.360.340.024.686.545 218:A03.556.124.684 247:G01.374.676.530  |ES| 2:1 9:1 10:1 14:1 19:1 45:1 52:1 75:1 261:1 288:1 356:1 641:1 661:1 750:1 798:1 850:1 1541:1 2406:1 2506:1 2641:1 3329:1 5416:1 5472:1  |EV| 
-1.858922722950069328362587839365  |BT| (S (ADVP (FW (In))(FW (vitro)))(, (,))(VP (NP (NN (TQ)))(VP (VBD (activated))(NP (NN (GSK-3beta))))(, (,))(VP (VBD (induced))(NP (JJ (membranous))(NN (localization))(NN (beta-catenin))))(VP (VBD (reduced))(NP (JJ (nuclear))(NN (c-myc))(NN (expression)))))) |ET|  |BS| 23:D12.776.091.249 1344:A10.615  |ES| 2:1 19:1 60:1 115:1 163:1 216:1 244:1 412:1 452:1 455:1 460:1 1256:1 2484:1 3653:1 5672:1  |EV| 
-0.66727646323295175534440204501152  |BT| (S (S (NP (NN (ERK)))(VP (VBD (mediated))(SBAR (S (NP (NN (upregulation))(NN (death))(NN (receptor))(CD (5)))(VP (VBZ (overcomes))(SBAR (S (NP (NN (lack))(NN (p53))(NN (functionality))(NN (diaminothiazole))(NN (DAT1)))(VP (VBD (induced))(NP (NN (apoptosis))(NN (colon))(NN (cancer))(NN (model)))))))))))(: (:))(S (NP (NN (efficiency))(NN (DAT1))(NN (Ras-Raf)))(NP (VBN (mutated))(NN (cell))))) |ET|  |BS| 1:G05.360.340.024.340.375.500.791.550 2:G05.360.340.024.340.375.249.385 39:G04.299.139.160 41:A11 249:G05.355.315.800 252:F02.784.692.351 339:G02.111.087.880  |ES| 12:1 18:1 19:1 72:1 89:1 94:1 104:1 113:1 186:1 229:1 411:1 412:1 437:1 578:1 868:1 1126:1 3239:1 3910:1 3915:1 3937:1 5047:1 5618:1 5619:1  |EV| 
-0.15147223916247654074140882585198  |BT| (NP (NN (Overexpression))(S (NP (NP (NN (c-Jun))(JJ (N-terminal))(NN (kinase))(CD (1)))(PRN (-LRB- (-LRB-))(NP (NN (JNK1)))(-RRB- (-RRB-))))(VP (VBD (resulted))(NP (NN (miR-122))(NN (down-regulation))(NN (induction))(NN (PTP1B)))))) |ET|  |BS| 85:G02.111.087.225 469:D08.811.913.696  |ES| 10:1 14:1 19:1 98:1 257:1 470:1 594:1 668:1 736:1 1686:1 1789:1 2357:1 5090:1 5091:1  |EV| 
-3.2009816039862366565671436546836  |BT| (NP (NP (NNS (AIMS)))(: (:))(S (NP (DT (The))(NN (aim))(NN (study)))(VP (VBP (examine))(NP (NN (effect))(NNS (NSAIDs))(NP (NN (mRNA))(NN (expression))(NN (tumour))(NN (suppressor))(JJ (adenomatous))(NN (polyposis))(NN (coli))(-LRB- (-LRB-))(NN (APC))(-RRB- (-RRB-))(NN (gene)))(NN (rat))(NN (colon))(NN (mucosa)))))) |ET|  |BS| 3:C04.557.470.035.215.100 21:G05.360.340.024.340.375.249.050 30:Z01.058.290.190.800 31:D08.811.520.224.800 46:A03.556.124.526.356 111:D13.444.735.544 155:G05.355.310 206:G05.360.340.024.340.375.249 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 302:A10.615.550 796:D27.505.696.663.850.014.040.500  |ES| 9:1 10:1 11:1 14:1 19:1 57:1 58:1 59:1 75:1 104:1 113:1 115:1 131:1 325:1 579:1 691:1 700:1 849:1 960:1 1011:1 1567:1 1778:1 2966:1  |EV| 
-0.78640224311284434577373758656904  |BT| (S (ADVP (RB (Additionally)))(, (,))(NP (NN (DNA))(NN (microarray))(NNS (data)))(VP (VBD (indicated))(SBAR (S (NP (NN (cell))(JJ (cycle-related))(NN (gene))(NNS (cyclins))(NN (CCNB1))(NN (CCNA2))(JJ (cyclin-dependent))(NN (kinase))(NN (inhibitor))(NN (CDKN3)))(ADVP (RB (also)))(VP (VBD (down-regulated))(NP (NP (NN (treatment)))(NP (CC (either))(NP (NN (PB))(NN (CF))(CD (13))(NN (week)))))))))) |ET|  |BS| 52:E02 142:I01.880.604 325:Z01.058.290.100.140 351:A17.360 979:D12.644.360.262.120.100 996:G05.360.340.024.340.220 1278:D12.644.360.262.100.200 1279:D12.644.360.225 1280:D12.644.360.262  |ES| 2:1 5:1 9:1 19:1 39:1 94:1 380:1 470:1 546:1 666:1 783:1 793:1 913:1 1100:1 1283:1 1532:1 1541:1 3496:1 4068:1 4542:1 4543:1 4544:1 4545:1 4546:1 4547:1  |EV| 
-0.9804155656490110004597227089107  |BT| (S (NP (NP (JJ (Global))(NN (gene))(NN (expression))(NN (analysis)))(NP (JJ (subsequent))(JJ (quantitative))(JJ (real-time))(JJ (reverse))(NN (transcription-polymerase))(NN (chain))(NN (reaction))))(VP (VBD (revealed))(NP (NN (BNF))(VBD (induced))(`` (`))(NP (NN (AhR))(NN (gene))(NN (battery'Cyp))(NN (1a1)))(, (,))(NP (NN (Cyp1a2)))(, (,))(NP (NN (Cyp1b1)))(, (,))(NP (NN (Nqo1)))(, (,))(NP (NN (Aldh3a1))(NN (Ugt1a6)))(RB (also))(NP (NP (NN (transcription))(NN (factor))(JJ (NF-E2-related))(NN (factor))(CD (2)))(PRN (-LRB- (-LRB-))(NP (NN (Nrf2)))(-RRB- (-RRB-))))(PRN (: (-))(NP (NP (VBN (regulated))(NN (gene))(NN (Gstm1))(, (,))(NN (Gpx2))(, (,))(NP (NP (NN (Akr7a3))(NN (Yc2)))(PRN (-LRB- (-LRB-))(ADVP (RB (also)))(NP (NN (Nqo1)))(-RRB- (-RRB-))))(, (,)))(NP (RB (presumably))(JJ (due))(JJ (adaptive))(NN (response))(JJ (BNF-triggered))(JJ (oxidative))(NN (stress))(NN (response)))))))) |ET|  |BS| 6:G05.360.340.024.340 142:I01.880.604 155:G05.355.310 197:A01.456.505.420 257:E05.393.620.500.706 346:E05.393.620.500.706 573:N05.715.350.200.650 591:G02.111.087.847.500 705:D08.244.453.040.443 716:G03.495.710 799:D12.776.260.615.249 1351:D08.244.453.040.500 1352:D08.244.453.040.332 1353:D12.776.260.262.500.750  |ES| 2:1 5:1 9:1 10:1 14:1 19:1 115:1 148:1 185:1 275:1 412:1 487:1 494:1 661:1 768:1 817:1 874:1 939:1 941:1 1319:1 2522:1 2583:1 2851:1 4037:1 4355:1 4830:1 4831:1 4832:1 4833:1 4834:1 4835:1 4836:1 4837:1 4838:1 4839:1 4840:1 4841:1 4842:1 4843:1 4844:1 4845:1 4846:1 4847:1  |EV| 
-0.1753822686254982166076388239162  |BT| (S (NP (NN (Cell))(NN (proliferation)))(ADVP (RB (significantly)))(VP (VBD (inhibited))(, (,))(SBAR (S (NP (NN (apoptosis)))(VP (VBD (induced))(NP (NP (NN (area))(NN (GST-P))(PRN (-LRB- (-LRB-))(CC (+))(-RRB- (-RRB-)))(NN (focus))(NNP (Valerian))(NN (group)))(VP (VBN (associated))(NP (NN (suppression))(NN (c-myc)))))(, (,))(NP (NP (NN (Mafb)))(, (,))(NP (NP (NN (cyclin))(NN (D1))(NN (induction))(NN (p21)))(PRN (-LRB- (-LRB-))(NP (NN (Waf1/Cip1)))(-RRB- (-RRB-))))(, (,))(NP (NN (p53))(NN (Bax))(NN (mRNA))(NN (expression))))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 39:G04.299.139.160 111:D13.444.735.544 122:C14.280.383 183:G04.299.233.750 215:D12.644.360.262.150.100 292:Z01 342:D12.644.360.075.718.400 857:B01.650.940.800.575.100.955.888 858:B01.650.940.800.575.100.955.888 1298:D12.776.260.108.500.061.500 1299:D12.644.360.225.500 1300:E05.318.308.112  |ES| 2:1 10:1 12:1 14:1 19:1 89:1 115:1 124:1 169:1 299:1 325:1 365:1 412:1 455:1 736:1 743:1 744:1 1135:1 1431:1 2300:1 2453:1 3057:1 3058:1 3059:1 4080:1 4094:1 4628:1 4629:1 4630:1  |EV| 
-1.4544521483537256045792673830874  |BT| (NP (NP (NN (CONCLUSION))(: (:)))(S (ADVP (RB (Collectively)))(, (,))(VP (VBP (result))(VP (VBP (suggest))(SBAR (S (NP (NN (curcumin)))(VP (VBZ (potentiates))(NP (NP (JJ (antitumor))(NN (effect))(NN (radiation))(NN (therapy)))(JJ (colorectal))(NN (cancer))(VBG (suppressing))(NP (NN (NF-kappaB))(JJ (NF-kappaB-regulated))(NN (gene))(NN (product))))(, (,))(NP (VBG (leading))(NN (inhibition))(NN (proliferation))(NN (angiogenesis)))))))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 7:D12.776 43:F01.145.544 52:E02 86:D01.268.556.435 142:I01.880.604 210:D12.776.260.600 692:D02.455.326.146.485.222.222 693:G01.750.745  |ES| 2:1 9:1 17:1 18:1 19:1 75:1 101:1 103:1 104:1 130:1 299:1 639:1 675:1 714:1 796:1 1872:1 1882:1 2244:1 2250:1 2498:1 2499:1 2500:1 2501:1 2502:1  |EV| 
-0.77696645785420059837633743882179  |BT| (S (NP (NP (NN (Inhibition))(JJ (isochaihulactone-induced))(NN (NAG-1))(NN (expression))(NN (EGR-1)))(ADJP (JJ (small))(S (VP (VBG (interfering))(NP (NN (RNA)))))))(VP (VBD (blocked))(NP (JJ (isochaihulactone-induced))(NN (apoptosis))(NN (A549))(NN (cell)))(, (,))(S (VP (VBG (suggesting))(NP (NN (induction))(NN (EGR-1))(NN (expression))(NN (decrease))(NN (survival))(NN (A549))(NN (cell))))))) |ET|  |BS| 39:G04.299.139.160 41:A11 43:F01.145.544 108:G04.299.316 117:D13.150.650.700 122:C14.280.383 580:D12.776.260.158.500  |ES| 2:1 19:1 89:1 94:1 115:1 274:1 295:1 364:1 515:1 736:1 750:1 1009:1 1662:1 2703:1 2777:1 3019:1 3874:1 4942:1  |EV| 
-1.548813871372772155154962092638  |BT| (FRAG (PP (IN (In))(NP (NN (addition))))(, (,))(NP (NP (NN (ERK5))(NN (inhibition)))(VP (VBD (increased))(NP (NP (NN (response))(NN (HCT116))(NN (p53)))(CC (+))(NP (: (/))(CC (+))(NN (cell))(NN (5-FU)))))(, (,)))(VBD (failed))(VB (sensitize))(NP (NP (NN (HCT116))(NN (p53)))(: (-)))(: (/))(: (-))(NP (NP (NN (cell))(JJ (cytotoxic))(NN (effect))(JJ (chemotherapeutic))(NN (agent)))(, (,))(VP (VBG (suggesting))(NP (NP (JJ (p53-dependent))(NN (axis)))(VP (VBG (mediating))(NP (NN (5-FU))(NN (sensitization)))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 30:Z01.058.290.190.800 31:D08.811.520.224.800 43:F01.145.544 560:D03.383.742.698.875.404 579:A02.835.232.834.151.383 660:D27.505.954.248 717:A11.251.210.190.380  |ES| 2:1 19:1 47:1 75:1 88:1 94:1 103:1 244:1 468:1 494:1 566:1 728:1 761:1 1009:1 1457:1 1505:1 1762:1 2089:1 2308:1 5471:1 5658:1 5659:1 5660:1 5661:1  |EV| 
-3.2009816039862366565671436546836  |BT| (FRAG (NP (NP (NP (NP (RB (Early))(NN (detection)))(JJ (2-amino-1-methyl-6-phenylimidazo))(-LRB- (-LRB-))(JJ (4,5-b))(-RRB- (-RRB-))(NN (pyridine))(-LRB- (-LRB-))(NN (PhIP))(-RRB- (-RRB-))(: (-)))(VBN (induced))(NN (mutation)))(PP (IN (within))(NP (NN (Apc))(NN (gene))(NN (rat))(NN (colon)))))) |ET|  |BS| 18:G05.365.590 21:G05.360.340.024.340.375.249.050 46:A03.556.124.526.356 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 494:E01.390 744:D03.383.725  |ES| 9:1 10:1 14:1 19:1 34:1 113:1 280:1 409:1 849:1 1023:1 2122:1 2638:1 2639:1 2640:1 2641:1 4135:1  |EV| 
-3.2009816039862366565671436546836  |BT| (S (PP (IN (In))(NP (NN (summary))))(, (,))(NP (NN (SAHA)))(VP (VP (VBD (inhibited))(S (NP (NN (growth))(JJ (human))(JJ (pancreatic))(NN (cancer))(NN (cell)))(VP (VBG (inducing))(NP (NN (apoptosis))))))(, (,))(NP (NP (NN (differentiation))(NN (cell))(NN (cycle))(NN (arrest)))(, (,))(ADVP (RB (well)))(NP (NN (increase))(NN (expression))(JJ (several))(NN (tumor))(NN (suppressor))(NN (gene)))))) |ET|  |BS| 39:G04.299.139.160 41:A11 45:G07.700.320.249 55:B01.050.150.900.649.801.400.112.400.400 74:G04.299.151 122:C14.280.383 206:G05.360.340.024.340.375.249 773:G04.299.134.109  |ES| 2:1 7:1 9:1 18:1 19:1 36:1 40:1 89:1 94:1 102:1 115:1 215:1 244:1 262:1 365:1 467:1 490:1 601:1 602:1 700:1 787:1 1864:1 4915:1  |EV| 
-0.73738951925037810042340424843132  |BT| (S (NP (NN (POX)))(ADVP (RB (markedly)))(VP (VBD (elevated))(SBAR (S (NP (JJ (p53-induced))(NN (apoptosis)))(VP (VBZ (generates))(NP (JJ (proline-dependent))(NP (NP (JJ (reactive))(NN (oxygen))(NN (specie)))(PRN (-LRB- (-LRB-))(NP (NN (ROS)))(-RRB- (-RRB-))))))))(, (,))(NP (NP (ADVP (RB (specifically)))(NP (NN (superoxide))(NN (radical))))(, (,))(NP (VBP (induce))(NN (apoptosis))(JJ (mitochondrial))(NN (death))(NN (receptor))(NN (pathway)))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 30:Z01.058.290.190.800 31:D08.811.520.224.800 39:G04.299.139.160 135:C23.550.260 565:A11.284.430.214.190.875.564 567:G05.360.340.024.340.365 636:D01.339.431 1185:D12.125.072.401.623 1405:D01.248.497.158.685.750.850  |ES| 2:1 10:1 14:1 19:1 89:1 146:1 186:1 243:1 383:1 411:1 480:1 756:1 1279:1 2004:1 2353:1 2354:1 2355:1 2356:1 2396:1 5101:1 5102:1 5103:1 5104:1  |EV| 
-3.2009815277111783871077932417393  |BT| (S (NP (NN (Rapamycin)))(VP (VBZ (inhibits))(SBAR (S (NP (JJ (multiple))(NN (stage))(NN (c-Neu/ErbB2)))(VP (VBD (induced))(NP (NP (NN (tumor))(NN (progression))(JJ (transgenic))(NN (mouse))(NN (model)))(NP (JJ (HER2-positive))(NN (breast))(NN (cancer))))))))) |ET|  |BS| 8:C04 16:C23.550.291.656 63:G05.360.340.024.340.375.500.791.295.305 65:D08.811.913.696.620.682.725.400.009.400 99:B01.050.050.136.500 122:C14.280.383 827:D02.540.505.760 1002:C04.588.180  |ES| 7:1 18:1 19:1 23:1 48:1 52:1 72:1 285:1 412:1 615:1 649:1 1129:1 2225:1 5115:1 5116:1  |EV| 
-0.025516891310059075514971027587308  |BT| (S (PP (IN (In))(NP (JJ (intestinal))(JJ (epithelial))(NN (cell))(NN (IEC-6))(NN (colon))(NN (cancer))(NN (cell))(NN (HCT-116))))(, (,))(NP (NN (IL-6))(NN (expression))(NN (signaling)))(VP (VBN (assessed))(NP (NP (NNP (SHH))(NN (inhibitor))(NN (level))(JJ (inflammatory))(NN (mediator)))(, (,))(NP (NP (NN (proliferation)))(, (,))(NP (NN (apoptosis)))(, (,))(NP (NN (tumorsphere))(NN (formation))))(, (,))(NP (NP (NN (tumorigenesis)))(VP (ADVP (RB (also)))(VBN (measured))))))) |ET|  |BS| 20:G03.495 32:C04.697.098.500 33:C04.697.098 39:G04.299.139.160 41:A11 47:A03.556.124 69:G02.111.087.800 75:A11.436 201:D12.644.276.374.465.224 228:E05.978 1523:E01.370.225.625.400 1524:E04.936.225.687.500  |ES| 2:1 5:1 18:1 19:1 43:1 78:1 89:1 94:1 109:1 113:1 115:1 127:1 195:1 244:1 249:1 299:1 380:1 738:1 789:1 2430:1 3148:1 3351:1 3823:1 5662:1 5663:1 5664:1  |EV| 
-1.4600485750407301566156093031168  |BT| (S (ADVP (RB (Importantly)))(, (,))(NP (NN (cotreatment))(JJ (low))(NNS (dos))(NP (NP (NNS (oligoamines))(NN (DNA))(NN (methyltransferase))(NN (inhibitor)))(ADVP (RB (highly)))))(VP (VBZ (induces))(SBAR (S (NP (NN (reexpression)))(ADVP (RB (aberrantly)))(VP (VBD (silenced))(SBAR (S (NP (NN (SFRP2))(NN (gene)))(VP (VBP (result))(NP (NP (JJ (significant))(NN (inhibition))(NN (growth)))(VBN (established))(NN (tumor))(JJ (human))(NN (colon))(NN (tumor))(NN (model)))(FW (vivo)))))))))) |ET|  |BS| 6:G05.360.340.024.340 8:C04 43:F01.145.544 45:G07.700.320.249 51:C04.588.274.476.411.307.180 55:B01.050.150.900.649.801.400.112.400.400 618:E02.186 746:D08.811.150.240  |ES| 2:1 7:1 9:1 19:1 36:1 72:1 101:1 102:1 103:1 113:1 135:1 214:1 378:1 380:1 531:1 626:1 666:1 2651:1 2652:1 2653:1 2654:1 2655:1 2656:1 2657:1 2658:1 2659:1 2660:1  |EV| 
-1.6671138715843838440378021914512  |BT| (S (PP (IN (In))(NP (JJ (AR-positive))(NN (bladder))(NN (cancer))(NN (cell))(NN (line))))(, (,))(NP (NN (dihydrotestosterone))(NN (treatment)))(VP (VP (VBD (increased))(NP (NP (NP (NN (ELK1)))(NN (expression)))(PRN (-LRB- (-LRB-))(NP (NP (NN (mRNA)))(, (,))(NP (NN (protein))))(-RRB- (-RRB-))))(S (VP (JJ (nuclear))(NP (NP (NN (translocation)))(, (,))(NP (NN (ELK1))(JJ (transcriptional))(NN (activity)))(, (,))(NP (NN (c-fos)))(NP (NN (expression)))(, (,))))))(VP (VBD (restored))(NP (JJ (anti-androgen))(NN (hydroxyflutamide)))))) |ET|  |BS| 7:D12.776 52:E02 94:A11.251.210 111:D13.444.735.544 165:G05.360.340.024.340.375.500.791.330 209:G02.111.087.847 463:C23.550.210.870 1287:D04.808.054.040.248 1288:D06.347.065 1366:D12.776.260.108.765  |ES| 2:1 4:1 10:1 14:1 18:1 19:1 47:1 94:1 115:1 244:1 264:1 325:1 399:1 546:1 558:1 559:1 562:1 564:1 1256:1 1618:1 4578:1 4892:1 4893:1 4894:1 4895:1  |EV| 
-1.3851773756001293236295168753713  |BT| (NP (NP (PP (IN (By))(NP (NN (contrast))))(, (,))(NP (NP (NP (NN (Ha-ras))(NN (mutation))(JJ (undetectable))(NN (tumor))(NN (mouse)))(VP (VBN (treated))(NP (NP (NN (DEN/PB)))(PRN (-LRB- (-LRB-))(NP (CD (0/32)))(-RRB- (-RRB-))))))(, (,))(NP (NP (QP (RB (approximately))(CD (80)))(NN (%)))(-LRB- (-LRB-))(CD (37/46))(-RRB- (-RRB-))(NN (tumor))(NN (group)))(NP (VBD (showed))(NN (beta-catenin))(NN (mutation)))))) |ET|  |BS| 1:G05.360.340.024.340.375.500.791.550 8:C04 11:B01.050.150.900.649.865.635.505.500 18:G05.365.590 23:D12.776.091.249 52:E02 216:Z01.107.084.900.425 491:D27.505.259.500 829:M01.686  |ES| 2:1 7:1 10:1 14:1 19:1 34:1 52:1 60:1 132:1 369:1 573:1 747:1 1099:1 1392:1 1843:1 1868:1 2300:1 4183:1 4609:1 4610:1 4611:1  |EV| 
-3.1033401453610274245420441729948  |BT| (FRAG (NN (Ku70))(: (-))(: (/))(: (-))(FRAG (S (NP (NNS (HCCs)))(VP (VBD (showed))(SBAR (S (NP (JJ (high))(JJ (proliferative))(NN (activity)))(VP (VBD (increased))(S (NP (NN (cyclin))(NN (D1)))(VP (VBG (proliferating))(NP (NN (cell))(JJ (nuclear))(NN (antigen))(NN (expression))))))))))(, (,))(NP (NP (NNP (Aurora))(NNP (A))(NN (kinase))(NN (activity)))(, (,))(VP (VP (VBD (enhanced))(NP (NP (NN (ataxia))(NN (telangiectasia)))(NP (VBN (mutated))(NN (kinase))(NN (ubiquitination)))))(, (,))(NP (NP (NN (loss))(NN (p53)))(PP (IN (via))(NP (NP (JJ (proteasomal))(NN (degradation)))(, (,))(S (NP (NN (feature)))(ADVP (RB (closely)))(VP (VBP (resemble))(NP (JJ (human))(NN (HCC)))))))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 55:B01.050.150.900.649.801.400.112.400.400 104:C04.557.470.200.025.255 215:D12.644.360.262.150.100 469:D08.811.913.696 520:C10.228.140.252.190.530.060 768:D12.776.660.740 1281:D05.500.562.500 1293:G03.495 1378:D08.811.913.696.620.682.700.103.500 1379:G02.111.087.675.871.790.600.925  |ES| 2:1 12:1 19:1 32:1 36:1 47:1 69:1 94:1 115:1 132:1 178:1 229:1 385:1 399:1 441:1 470:1 596:1 597:1 743:1 744:1 855:1 1030:1 1132:1 1250:1 1256:1 2865:1 4117:1 4556:1 4982:1 4983:1 4984:1 4985:1 4986:1 4987:1  |EV| 
-1.1403608935240612254347070120275  |BT| (SINV (SBAR (IN (Whether))(S (NP (NP (JJ (single))(NN (cell)))(NP (NP (ADJP (RB (immunohistochemically))(JJ (positive)))(NN (glutathione))(NN (S-transferase))(NN (P1-1)))(PRN (-LRB- (-LRB-))(NP (NN (GSTP1-1)))(-RRB- (-RRB-)))))(VP (VBD (induced))(NP (JJ (female))(NN (mouse))(NN (liver))(NN (DEN))))))(PRN (-LRB- (-LRB-))(NP (NP (NNP (Hatayama))(FW (et))(FW (al.)))(, (,))(NP (NN (Carcinogenesis)))(, (,))(CD (14))(, (,))(CD (537-538))(, (,))(NP (CD (1993))))(-RRB- (-RRB-)))(NP (NP (NN (precursor))(VBD (initiated))(NN (cell))(JJ (preneoplastic))(NN (focus)))(, (,))(NP (NN (importance))(NN (chemical))(NN (hepatocarcinogenesis))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 33:C04.697.098 41:A11 242:A03.620 642:M01.975 805:F01.829.263.315.500.725 806:F01.829.263.315.500.725 897:Z01.252.245.500.375 962:A11.148.378 1276:D08.811.913.225.500.500  |ES| 2:1 10:1 14:1 19:1 52:1 94:1 233:1 412:1 836:1 900:1 1404:1 1431:1 1438:1 1440:1 1660:1 1875:1 1900:1 2124:1 2744:1 2745:1 2846:1 3167:1 4519:1 4520:1 4521:1 4522:1 4523:1 4524:1 4525:1 4526:1 4527:1 4528:1  |EV| 
-0.43464181190870476712007075548172  |BT| (NP (NP (NN (OBJECTIVE)))(: (:))(NP (NP (PRP (We)))(VP (VBD (aimed))(NP (NN (test))(IN (whether))(NP (NP (NN (association))(JJ (colorectal))(NN (polyp))(NN (intake))(NN (calcium)))(, (,))(NP (NN (magnesium)))(, (,))(NP (NP (NN (Thr1482Ile))(NN (polymorphism))(NN (TRPM7))(NN (gene)))(VP (VBN (modified))(NP (NN (Ca)))))(: (:)))(NN (Mg))(NN (intake)))))) |ET|  |BS| 6:G05.360.340.024.340 30:Z01.058.290.190.800 31:D08.811.520.224.800 307:G05.365.795 386:F02.463.425.069 415:F01.658.500 444:C23.300.825 1026:Z01.252.474.651 1507:A08.186.211.464.405 1508:D01.268.552.437 1509:D01.268.552.100 1510:D01.146.315  |ES| 2:1 9:1 17:1 19:1 104:1 221:1 647:1 843:1 844:1 1060:1 1298:1 1417:1 1418:1 2335:1 2563:1 5564:1 5565:1 5566:1 5567:1 5568:1 5569:1  |EV| 
-0.10860792309841893477084795449628  |BT| (VP (NP (NP (NP (NN (Androgen)))(PRN (-LRB- (-LRB-))(NP (NP (NN (R1881)))(, (,))(NP (NN (dihydrotestosterone))))(-RRB- (-RRB-))))(NN (treatment))(NP (NP (NN (SVHUC))(VBN (immortalized))(JJ (normal))(JJ (urothelial))(NN (cell)))(ADVP (RB (stably)))(VP (VBG (expressing))(NP (NP (NN (AR)))(PRN (-LRB- (-LRB-))(NP (NN (SVHUC-AR)))(-RRB- (-RRB-)))))))(VP (VBD (decreased))(NP (NN (GATA3))(NN (expression))(NN (mRNA))(NN (protein))(NN (level))))(, (,))(VP (VBD (abolished))(NP (NNS (anti-androgens))))) |ET|  |BS| 7:D12.776 41:A11 52:E02 111:D13.444.735.544 321:A10.272.850 892:D27.505.696.399.472.161 1287:D04.808.054.040.248 1288:D06.347.065 1289:D04.808.365.415.550  |ES| 2:1 4:1 10:1 14:1 19:1 94:1 115:1 118:1 202:1 249:1 325:1 478:1 546:1 810:1 1078:1 1357:1 1852:1 2152:1 4577:1 4578:1 4579:1 4580:1 4581:1 4582:1 4583:1  |EV| 
-1.0681565002794002339214785024524  |BT| (FRAG (PP (IN (Because))(NP (NP (NN (combination))(JJ (anti-EGFR))(NN (5-fluorouracil))(-LRB- (-LRB-))(NP (NN (5-FU))(-RRB- (-RRB-))(: (-)))(VP (VBN (based))(NP (NN (chemotherapy))(JJ (promising))(NN (treatment)))))(, (,))(SBAR (S (NP (VBN (analyzed))(NN (effect))(NN (K-Ras))(NN (mutation))(NN (patient)))(VP (VBD (received))(NP (JJ (exclusive))(NN (5-FU))(NN (therapy))))))))) |ET|  |BS| 1:G05.360.340.024.340.375.500.791.550 18:G05.365.590 50:M01.643 52:E02 151:E02.319 333:D01.045 560:D03.383.742.698.875.404  |ES| 2:1 10:1 13:1 14:1 19:1 34:1 75:1 120:1 130:1 495:1 530:1 546:1 549:1 1168:1 1517:1 1862:1 2307:1 2308:1 2895:1 4339:1 5576:1  |EV| 
-1.9542864697601878276600473327562  |BT| (S (NP (PRP$ (Our))(NN (result)))(VP (VBD (showed))(SBAR (S (NP (NNP (Protandim)))(VP (VBD (suppressed))(NP (JJ (mitochondrial))(NN (translocation))(NN (p53))(JJ (mitochondrial))(JJ (outer))(NN (membrane))(NN (protein))(NN (Bax)))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 342:D12.644.360.075.718.400 463:C23.550.210.870 565:A11.284.430.214.190.875.564 567:G05.360.340.024.340.365 1402:A11.284.149.450.349  |ES| 4:1 12:1 19:1 101:1 132:1 307:1 658:1 1618:1 2004:1 3622:1 4630:1 5088:1 5089:1  |EV| 
-1.1565580228148064634297043085098  |BT| (NP (NP (NP (S (NP (NP (NN (Gene))(NN (expression))(NN (analysis))(NN (Bcl-2))(NN (family))(NN (gene)))(NP (JJ (antioxidant))(NN (enzyme))))(VP (VBD (revealed))(NP (NP (NN (t-PTER)))(CC (+))(NP (NN (QUER)))(NP (NN (treatment))))(SBAR (S (ADVP (RB (preferentially)))(VP (VBZ (promotes)))))))(, (,))(NP (NN (HT-29))(NN (cell)))(ADVP (VBG (growing))(FW (vivo)))(, (,))(-LRB- (-LRB-))(NP (NP (NP (-RRB- (-RRB-))(NN (superoxide))(NN (dismutase))(CD (2))(NN (overexpression)))(PRN (-LRB- (-LRB-))(NP (ADJP (ADJP (RB (approximately))(JJ (5.7-fold)))(, (,))(ADJP (IN (via))(NN (specificity))))(NN (protein))(JJ (1-dependent))(NN (transcription))(NN (regulation)))(-RRB- (-RRB-))))(PRN (-LRB- (-LRB-))(NP (NN (b)))(-RRB- (-RRB-))))(NP (NP (NN (down-regulation))(NN (bcl-2))(NN (expression)))(PRN (-LRB- (-LRB-))(ADVP (RB (approximately))(RB (3.3-fold)))(, (,)))))(PP (IN (via))(NP (NN (inhibition))(JJ (nuclear))(NN (factor-kappaB))(NN (activation)))))(ADJP (-RRB- (-RRB-)))) |ET|  |BS| 43:F01.145.544 44:F01.829.263 52:E02 54:G05.360.340.024.340.375.500.791.150 85:G02.111.087.225 142:I01.880.604 155:G05.355.310 209:G02.111.087.847 210:D12.776.260.600 700:D27.505.519.217 730:D08.811 792:A11.251.210.190.475 1050:D12.776.157.125.050.060 1052:D12.776.641.750 1224:E05.318.740.872  |ES| 2:1 4:1 9:1 10:1 14:1 19:1 94:1 97:1 103:1 115:1 146:1 147:1 148:1 151:1 152:1 158:1 166:1 167:1 225:1 257:1 275:1 298:1 378:1 438:1 487:1 546:1 596:1 661:1 1233:1 1256:1 1843:1 2388:1 2521:1 2702:1 2782:1 3059:1 3532:1 4819:1 4820:1 4821:1 4822:1 4823:1 4824:1  |EV| 
-3.1999054964014703728025779128075  |BT| (S (NP (NN (Salinomycin)))(VP (VBD (induced))(NP (NN (degradation))(NN (Skp2)))(ADVP (RB (thus)))(VP (VBN (accumulated))(NP (NN (p27Kip1)))))) |ET|  |BS| 338:D12.644.360.225.600 507:D12.776.157.743 1293:G03.495  |ES| 19:1 412:1 597:1 1334:1 1785:1 4616:1 5153:1 5154:1  |EV| 
-1.6826604215875136105751153081656  |BT| (S (ADVP (RB (Furthermore)))(, (,))(NP (NP (NN (calcitriol)))(PRN (-LRB- (-LRB-))(NP (JJ (active))(NN (form))(NN (vitamin))(NN (D)))(-RRB- (-RRB-))))(VP (VBD (suppressed))(NP (NN (CYP3A4))(NN (expression))(VBG (activating))(NN (miR-627))))) |ET|  |BS| 189:V02.460 720:D04.808.247.222.474 721:D04.808.812.768 1347:D04.808.247.222.159.478.387.300 1348:D08.244.453.400  |ES| 2:1 10:1 14:1 19:1 115:1 197:1 307:1 334:1 630:1 1958:1 2591:1 2592:1 4803:1 4804:1 4805:1  |EV| 
-1.5732605263322056998731568455696  |BT| (S (ADVP (RBR (More))(RB (importantly)))(, (,))(NP (NN (ATRA)))(VP (VBD (downregulated))(NP (NN (expression))(NNP (CSC))(NN (marker))(NN (CD44))(NN (ALDH)))(SBAR (S (NP (ADJP (RB (well))(JJ (stemness)))(NN (gene))(NN (Klf4))(NN (Sox2)))(VP (VBD (induced))(NP (NN (differentiation))(NNS (tumorspheres)))))))) |ET|  |BS| 6:G05.360.340.024.340 74:G04.299.151 158:D23.101 556:C11.768.175 770:D02.455.326.271.665.202.495.818.500 1387:D12.776.260.719.100  |ES| 2:1 9:1 19:1 115:1 215:1 412:1 426:1 534:1 787:1 1581:1 2767:1 2768:1 3577:1 5020:1 5021:1 5022:1 5023:1 5024:1 5025:1  |EV| 
-0.044682741342626286495942622423172  |BT| (S (SBAR (IN (For))(S (NP (NN (therapy)))(VP (VBD (advanced))(NP (NNP (MTC))))))(, (,))(NP (NNP (Food))(NNP (Drug))(NNP (Administration)))(ADVP (RB (recently)))(VP (VBD (approved))(NP (NP (NP (NN (vandetanib))(NN (cabozantinib))(, (,))(NN (tyrosine))(NN (kinase))(NN (inhibitor)))(VP (VBG (targeting))(NP (NNP (RET)))))(, (,))(NP (NP (JJ (vascular))(JJ (endothelial))(NN (growth))(NN (factor))(NN (receptor)))(, (,))(NP (NP (JJ (epidermal))(NN (growth))(NN (factor))(NN (receptor)))(CC (and/or))(NP (NN (c-MET)))))))) |ET|  |BS| 52:E02 64:D08.811.913.696.620.682.725.400.009.300 633:I01.409.418.750.600.650.760 1339:D08.811.913.696.620.682.725.400.950 1340:D08.811.913.696.620.682.725  |ES| 2:1 19:1 102:1 130:1 149:1 184:1 185:1 186:1 380:1 470:1 616:1 772:1 956:1 997:1 1251:1 2341:1 2343:1 2344:1 2345:1 2346:1 3092:1 3489:1 4778:1 4779:1 4780:1 4781:1  |EV| 
-1.0215984983090038440423086285591  |BT| (S (NP (NNP (Emodin)))(ADVP (RB (also)))(VP (VBD (inhibited))(NP (NP (NN (growth))(NN (lung))(NN (xenograft))(NN (tumor))(NN (Sp1)))(, (,))(NP (VBD (increased))(NN (IGFBP1))(NN (PPARgamma))(NN (protein))(NN (expression)))(ADVP (FW (In))(FW (vivo)))))) |ET|  |BS| 7:D12.776 45:G07.700.320.249 92:E04.936.764 93:A01.941.875 122:C14.280.383 237:C04.588.894.797.520 719:D12.776.826.239.588 1327:D12.776.157.420.250 1518:D02.455.426.559.847.117.159.205.400  |ES| 2:1 4:1 5:1 7:1 19:1 47:1 102:1 115:1 244:1 265:1 328:1 365:1 378:1 2588:1 4856:1 5612:1 5613:1  |EV| 
-0.64843412075543938044575043022633  |BT| (NP (NP (NP (NN (Regulation))(NN (PTEN))(NN (expression))(JJ (intestinal))(JJ (epithelial))(NN (cell))(NN (c-Jun))(JJ (NH2-terminal))(NN (kinase))(NN (activation)))(NP (JJ (nuclear))(NN (factor-kappaB))(NN (inhibition))))) |ET|  |BS| 43:F01.145.544 47:A03.556.124 75:A11.436 142:I01.880.604 210:D12.776.260.600 771:D08.811.913.696.620.682.700.567.374  |ES| 19:1 94:1 103:1 109:1 115:1 127:1 225:1 470:1 699:1 1256:1 1686:1 1936:1 2702:1 2708:1  |EV| 
-0.62547462798352171375881880521774  |BT| (S (SBAR (IN (Although))(S (NP (NP (NP (NN (Mlh1)))(PRN (-LRB- (-LRB-))(NP (NN (G67R)))(-RRB- (-RRB-))))(NN (mutation)))(VP (VBD (resulted))(NP (NN (DNA))(NN (repair))(NN (deficiency))(JJ (homozygous))(JJ (mutant))(NN (mouse))))))(, (,))(VP (VBP (affect))(SBAR (S (NP (NP (JJ (MMR-mediated))(JJ (cellular))(NN (response))(NN (DNA))(NN (damage)))(, (,))(PP (VBG (including))(NP (NP (JJ (apoptotic))(NN (response))(JJ (epithelial))(NN (cell))(JJ (intestinal))(NN (mucosa))(NN (cisplatin)))(, (,))(NP (NP (JJ (defective))(NN (Mlh1)))(PRN (-LRB- (-LRB-))(: (-))(: (/))(: (-))(-RRB- (-RRB-))))(NP (NN (mouse))))))(VP (VBD (remained))(NP (NP (NP (JJ (normal))(NN (Mlh1)))(PRN (-LRB- (-LRB-))(NP (NN (G67R/G67R)))(-RRB- (-RRB-))))(NN (mouse)))))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 18:G05.365.590 39:G04.299.139.160 41:A11 191:A03.556.124.369 433:F01.470.047 498:D01.210.375 526:G05.355.180 1282:C18.452.284 1283:G05.380.554  |ES| 2:1 10:1 14:1 19:1 34:1 45:1 52:1 94:1 107:1 109:1 118:1 127:1 253:1 494:1 513:1 561:1 579:1 586:1 594:1 666:1 811:1 1486:1 1761:1 1848:1 1861:1 2223:1 3074:1 4563:1 4564:1 4565:1 4566:1 4567:1  |EV| 
-1.4303694532500230707228183746338  |BT| (S (NP (NN (GST-P))(NN (gene))(NN (expression))(VBN (linked))(NN (reporter))(NN (gene)))(ADVP (RB (specifically)))(VP (VBD (suppressed))(NP (NP (NN (cotransfection))(NN (PPAR))(NN (alpha))(NN (expression))(NN (plasmid))(NN (presence))(NN (peroxisome))(NN (proliferator)))(, (,))(NP (NN (clofibrate)))))) |ET|  |BS| 155:G05.355.310 457:G05.360.600 536:D12.776.826.239.500 910:D02.241.081.114.968.500.500.195 912:D27.888.569.100.675 1355:G05.360.340.024.340.435  |ES| 2:1 9:1 19:1 115:1 288:1 307:1 346:1 1279:1 1363:1 1597:1 1836:1 1887:1 1888:1 3058:1 3200:1 3227:1 4852:1  |EV| 
-1.1047363225733928260297034285031  |BT| (S (NP (NNS (Analyses))(NN (xenograft)))(VP (VBD (showed))(SBAR (S (NP (NP (JJ (similar))(NN (cell))(NN (culture))(NN (finding)))(, (,))(NP (NN (silibinin))(NN (decrease))(NN (proliferation))(NN (expression))(NN (beta-catenin)))(, (,))(NP (NN (cyclin))(NN (D1)))(, (,))(NP (NP (NN (c-Myc)))(, (,))(NP (NN (CDK8)))))(VP (VBZ (induces))(NP (NN (apoptosis)))(ADVP (FW (vivo)))))))) |ET|  |BS| 23:D12.776.091.249 39:G04.299.139.160 92:E04.936.764 93:A01.941.875 215:D12.644.360.262.150.100 1514:E01.370.225.500.223  |ES| 2:1 19:1 60:1 89:1 94:1 115:1 132:1 214:1 265:1 295:1 299:1 332:1 378:1 743:1 744:1 824:1 927:1 2635:1 3098:1 5574:1 5575:1  |EV| 
-0.88762134238925227691652253270149  |BT| (S (NP (DT (An))(JJ (apoptosis-related))(NN (gene))(NN (expression))(NN (profiling))(NN (analysis)))(VP (VBD (provided))(SBAR (S (NP (NP (NP (NN (clue))(JJ (death-associated))(NN (protein))(NN (kinase))(CD (1)))(PRN (-LRB- (-LRB-))(NP (NN (dapk1)))(-RRB- (-RRB-))))(NN (gene)))(VP (VBN (upregulated))(NP (ADJP (JJS (least))(JJ (twofold)))(NN (response))(NN (grifolin))(NN (treatment))(JJ (nasopharyngeal))(NN (carcinoma))(NN (cell))(NN (CNE1)))))))) |ET|  |BS| 6:G05.360.340.024.340 39:G04.299.139.160 41:A11 52:E02 718:E05.588.570 1285:D08.811.913.696.620.682.700.125.387 1286:E05.393.332  |ES| 4:1 9:1 10:1 14:1 19:1 94:1 98:1 115:1 125:1 304:1 470:1 494:1 546:1 661:1 1015:1 1142:1 1155:1 1178:1 1331:1 2148:1 4571:1 4572:1 4573:1 4574:1 4575:1 4576:1  |EV| 
-0.005709841885561672825133427977562  |BT| (S (NP (NP (JJ (Dietary))(NN (intake))(NN (pterostilbene)))(, (,))(NP (NN (constituent))(NN (blueberry)))(, (,)))(VP (VBZ (inhibits))(NP (NN (beta-catenin/p65))(JJ (downstream))(NN (signaling))(NN (pathway))(NN (colon))(NN (carcinogenesis))(NN (rat))))) |ET|  |BS| 23:D12.776.091.249 33:C04.697.098 46:A03.556.124.526.356 69:G02.111.087.800 122:C14.280.383 126:G02.111.087.800 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 595:G07.203.650.240 710:B01.650.940.800.575.100.343.774.249  |ES| 2:1 19:1 113:1 195:1 207:1 383:1 560:1 615:1 849:1 2428:1 2457:1 2562:1 2563:1 2564:1 2565:1  |EV| 
-0.33501591869560343184275552630424  |BT| (S (NP (NN (K-Ras))(NN (mutation))(NN (treatment))(NN (outcome))(JJ (colorectal))(NN (cancer))(NN (patient)))(VP (VBG (receiving))(NP (JJ (exclusive))(NN (fluoropyrimidine))(NN (therapy))))) |ET|  |BS| 1:G05.360.340.024.340.375.500.791.550 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 18:G05.365.590 50:M01.643 52:E02 164:E01.789.800  |ES| 13:1 17:1 18:1 19:1 34:1 120:1 130:1 546:1 547:1 548:1 549:1 550:1  |EV| 
-0.00048522894394409377127885818481445  |BT| (S (NP (NN (Isochaihulactone))(NN (treatment)))(VP (VBD (increased))(NP (NP (NN (luciferase)))(NP (NN (activity))(NN (NAG-1))(NN (A549))(NN (cell)))(NP (VBN (transfected))(NN (NAG-1))(NN (promoter))(NN (construct)))))) |ET|  |BS| 41:A11 52:E02 1375:D08.811.682.517  |ES| 19:1 47:1 83:1 94:1 364:1 399:1 479:1 546:1 1662:1 4962:1 4963:1 4964:1  |EV| 
-1.1182814001031715633871499449015  |BT| (SBAR (IN (From))(S (NP (NN (list)))(ADVP (RB (differentially)))(VP (VBD (expressed))(NP (NP (NP (NN (gene))(VBN (prioritized))(NN (transcriptome))(NN (profiling)))(, (,))(NP (NN (Mmp7)))(, (,))(NP (NN (S100a9)))(, (,))(NP (NP (NN (Nppb))(NN (Aldh1a3)))(NP (VBN (defined))(NN (key))(NN (oncogene))(NN (candidate)))))(VP (VBD (downregulated))(NP (NN (colon))(NN (tumor))(NNP (TA))(NN (treatment)))))))) |ET|  |BS| 6:G05.360.340.024.340 9:G05.360.340.024.340.375.500 51:C04.588.274.476.411.307.180 52:E02 937:D08.811.277.656.300.480.525.700.250 1286:E05.393.332  |ES| 2:1 6:1 7:1 9:1 19:1 24:1 113:1 159:1 426:1 546:1 680:1 1139:1 1243:1 2148:1 5637:1 5638:1 5639:1 5640:1 5641:1 5642:1 5643:1 5644:1 5645:1  |EV| 
-0.77590880046136589953675866127014  |BT| (NP (NP (ADJP (NN (Correction))(JJ (malignant)))(NN (behavior))(ADJP (NN (tumor))(NN (cell))(JJ (traditional)))(JJ (Chinese))(NN (herb))(NN (medicine))(NN (restoration))(NN (p53)))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 38:Z01.058.290.120.180 40:Z01.542.248.700 41:A11 788:H01.158.273.118.598.500 876:F01.145 1320:E02.190.488.585.520  |ES| 7:1 12:1 19:1 94:1 802:1 2326:1 2327:1 2763:1 2764:1 4704:1 4705:1 4706:1  |EV| 
-0.14098232670420429712976329028606  |BT| (S (ADVP (RB (Moreover)))(, (,))(NP (NN (inhibition))(NN (SHP-1))(NN (gene))(JJ (small))(NN (interference))(NN (RNA)))(VP (VBD (abolished))(SBAR (S (NP (NN (ability))(NN (evodiamine)))(VP (VBP (inhibit))(NP (NP (NP (JJ (IL-6-induced))(NN (STAT3)))(PRN (-LRB- (-LRB-))(NP (NP (NN (Tyr)))(PRN (-LRB- (-LRB-))(NP (CD (705)))(-RRB- (-RRB-))))(-RRB- (-RRB-))))(NN (activation)))))))) |ET|  |BS| 6:G05.360.340.024.340 30:Z01.058.290.190.800 31:D08.811.520.224.800 43:F01.145.544 82:D12.644.360.024.342.300 122:C14.280.383 201:D12.644.276.374.465.224 385:F02.784.629.131 634:D12.125.072.050.875 1206:D08.811.682.690.708.125.500 1422:D13.444.735  |ES| 2:1 9:1 10:1 14:1 19:1 103:1 225:1 251:1 515:1 516:1 622:1 682:1 750:1 1300:1 1370:1 4232:1 4582:1 5577:1 5685:1 5686:1  |EV| 
-0.084057235229749949212418869137764  |BT| (NP (NP (JJ (Negative))(NN (regulation))(JJ (oncogenic))(NN (transcription))(NN (factor))(NN (FoxM1))(NNS (thiazolidinediones))(NN (mithramycin)))) |ET|  |BS| 142:I01.880.604 166:D12.776.930 279:D27.888.569.100 862:D02.886.675.933 1303:D02.455.426.559.847.562.050.650  |ES| 19:1 185:1 438:1 487:1 953:1 3118:1 4659:1 4791:1 5045:1  |EV| 
-1.5832285188547814414050662890077  |BT| (S (ADVP (RB (Here)))(, (,))(VP (VBP (describe))(NP (JJ (functional))(NN (characterization))(JJ (novel))(NN (rat))(JJ (mutant))(NN (model))(NN (MMR))(NN (gene))(NN (Msh6)))(SBAR (S (ADVP (RB (genetically)))(VP (VBD (inactivated))(NP (JJ (N-ethyl-N-nitrosourea-driven))(JJ (target-selected))(NN (mutagenesis)))))))) |ET|  |BS| 6:G05.360.340.024.340 66:F01.658.293 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 259:D12.776.395.240.150.500 1359:G05.355.600 1360:D02.654.692  |ES| 2:1 9:1 19:1 72:1 400:1 415:1 811:1 849:1 891:1 898:1 1735:1 2134:1 4859:1 4860:1 4861:1 4862:1 4863:1 4864:1  |EV| 
-0.082979924914639013877604156732559  |BT| (S (S (NP (NNP (Mevalonate)))(VP (VBD (decreased))(NP (NP (JJ (simvastatin-induced))(NN (AMPK))(NN (activation)))(VP (VBD (rescued))(NP (JJ (phospho-STAT3))(NN (Skp2))(NN (expression))(NN (HCC))(NN (cell)))))))(, (,))(VP (VBD (resulted))(NP (NN (prevention))(NN (G0/G1))(NN (arrest))(NN (inhibition))(NN (p21))(NN (p27))(NN (accumulation))))) |ET|  |BS| 41:A11 43:F01.145.544 82:D12.644.360.024.342.300 104:C04.557.470.200.025.255 507:D12.776.157.743 754:D02.455.426.559.847.638.400.900 1526:D02.241.511.579  |ES| 2:1 19:1 94:1 103:1 115:1 202:1 225:1 441:1 594:1 602:1 1124:1 1135:1 1474:1 1785:1 2120:1 4692:1 5665:1 5666:1 5682:1 5683:1 5684:1  |EV| 
-0.32214191445018514059484004974365  |BT| (NP (NP (NP (NNS (METHODS)))(CC (AND))(NP (NNS (RESULTS)))(: (:)))(S (NP (JJ (Endogenous))(NN (ROS))(NN (production))(JJ (CYP2E1-expressing))(NN (HepG2))(NN (cell)))(VP (VBD (induced))(NP (NP (NP (NN (mRNA))(NN (protein))(NN (expression))(NN (KLF6)))(PRN (-LRB- (-LRB-))(ADJP (JJ (Full)))(-RRB- (-RRB-))))(NN (splice))(NN (variant)))(S (VP (VBN (compared))(NP (NN (control))(NN (cell)))))))) |ET|  |BS| 7:D12.776 30:Z01.058.290.190.800 31:D08.811.520.224.800 41:A11 111:D13.444.735.544 168:E05.581 1015:A11.251.860.180.432 1218:D08.244.453.300  |ES| 4:1 10:1 14:1 19:1 50:1 94:1 104:1 115:1 289:1 325:1 412:1 565:1 688:1 710:1 990:1 2356:1 2677:1 3481:1 4116:1 4683:1 4684:1 5004:1 5005:1  |EV| 
-0.27812970384141522117715794593096  |BT| (S (SBAR (IN (Although))(S (NP (NN (study)))(VP (VBD (needed))(VP (VB (prove))(SBAR (S (NP (VBN (increased))(NN (expression))(NN (Egr-1))(NN (PTX-2)))(VP (ADVP (RB (directly)))(VBP (lead))(NP (NP (NN (NAG-1))(NN (induction))(NN (apoptosis))(NN (induction)))(NP (JJ (p53-deficient))(NN (Hep3B))(NN (cell)))))))))))(, (,))(VP (VBP (result))(SBAR (S (NP (NN (study)))(VP (VBP (suggest))(SBAR (S (NP (NN (PTX-2)))(VP (MD (may))(NP (JJ (good))(NN (candidate))(NN (development))(JJ (potential))(JJ (anti-tumorigenic))(NN (agent))(JJ (p53-deficient))(NN (tumor))))))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 8:C04 30:Z01.058.290.190.800 31:D08.811.520.224.800 39:G04.299.139.160 41:A11 86:D01.268.556.435 284:N03.349.380.420 1272:D03.438.759.758.824.651.700  |ES| 2:1 7:1 19:1 35:1 47:1 89:1 94:1 101:1 107:1 115:1 131:1 254:1 491:1 621:1 728:1 736:1 796:1 827:1 981:1 1243:1 1318:1 1662:1 2669:1 4498:1 4502:1 4560:1 4561:1 4562:1  |EV| 
-0.27124440439345676168159116059542  |BT| (S (NP (NN (Erlotinib)))(VP (VBZ (induces))(NP (NP (JJ (mitochondrial-mediated))(NN (apoptosis)))(NP (NP (JJ (human))(NN (H3255))(JJ (non-small-cell))(NN (lung))(ADJP (NN (cancer))(NN (cell))(JJ (epidermal)))(NN (growth))(NN (factor))(NN (receptorL858R))(NN (mutation)))(NP (JJ (mitochondrial))(JJ (oxidative))(JJ (phosphorylation-dependent))(NN (activation))(NN (BAX))(NN (BAK))))))) |ET|  |BS| 18:G05.365.590 39:G04.299.139.160 41:A11 55:B01.050.150.900.649.801.400.112.400.400 110:C04.588.894.797.520.109.220.249 342:D12.644.360.075.718.400 565:A11.284.430.214.190.875.564 567:G05.360.340.024.340.365 923:D06.472.317.350 1336:G02.111.087.677.550  |ES| 18:1 19:1 34:1 36:1 89:1 94:1 102:1 184:1 185:1 214:1 225:1 327:1 328:1 2004:1 2583:1 2596:1 4769:1 4770:1 4771:1 4772:1 4773:1 4774:1  |EV| 
-0.11808012598703498952090740203857  |BT| (S (ADVP (RB (Conversely)))(, (,))(NP (NP (NN (MBO-asGCS))(NN (treatment)))(VP (VBD (decreased))(NP (NP (NP (NN (globo))(NN (series))(NNS (GSLs)))(PRN (-LRB- (-LRB-))(NP (NP (NN (Gb3)))(, (,))(NP (NN (Gb4))))(-RRB- (-RRB-))))(, (,))(NP (NN (cSrc))(NN (kinase))(JJ (nuclear))(NN (beta-catenin)))(, (,)))))(VP (VBD (suppressed))(NP (NN (MDR-1))(NN (expression))(JJ (dose-dependent))(NN (pattern))))) |ET|  |BS| 23:D12.776.091.249 52:E02 469:D08.811.913.696  |ES| 2:1 10:1 14:1 19:1 60:1 115:1 202:1 260:1 307:1 470:1 546:1 1256:1 1807:1 2824:1 3404:1 4697:1 4698:1 4699:1 4700:1 4701:1 4702:1 4703:1  |EV| 
-0.025633185875562958244699984788895  |BT| (FRAG (PP (IN (In))(NP (NN (LNCaP))(NN (cell))))(, (,))(NP (NP (JJ (caspase-mediated))(NN (apoptosis))(NN (induction))(NN (PGG)))(SBAR (S (NP (VBN (associated))(JJ (mediated))(JJ (major))(NN (part))(NN (activation))(NN (p53)))(VP (VBD (established))(NP (JJ (small))(VBG (interfering))(NN (RNA))(NN (knockdown))(JJ (dominant-negative))(JJ (mutant))(NN (approach)))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 38:Z01.058.290.120.180 39:G04.299.139.160 40:Z01.542.248.700 41:A11 117:D13.150.650.700 133:D01.248.497.158.685.750.744.600 1367:D08.811.277.656.262.500.126  |ES| 2:1 12:1 19:1 89:1 94:1 169:1 225:1 244:1 413:1 437:1 451:1 462:1 464:1 515:1 736:1 750:1 811:1 911:1 2115:1 2660:1 3019:1 4904:1 4905:1  |EV| 
-0.18127751031339300880063092336059  |BT| (S (ADVP (RB (Remarkably)))(, (,))(NP (NP (NN (F-box))(NN (protein))(NN (FBW7)))(, (,))(NP (NN (E3-ubiquitin))(NN (ligase)))(, (,)))(VP (VBN (controlled))(NP (NP (NN (stability))(NN (arm))(NN (c-MYC/MXD1))(JJ (push-pull))(NN (network)))(, (,))(NP (NN (FBW7))(NN (ablation)))))(S (VP (VBD (attenuated))(NP (CD (1,25))(NN (D))(NN (regulation))(NN (c-MYC))(NN (MXD1))(NN (turnover)))))) |ET|  |BS| 142:I01.880.604 588:I01.880.853.500.600 665:N04.452.677.680 1408:C04.557.450.590.550.660.665 1409:D08.811.464.938.750 1410:A01.378.800.075  |ES| 2:1 4:1 19:1 91:1 438:1 625:1 808:1 2154:1 2424:1 4529:1 4533:1 4950:1 5094:1 5123:1 5124:1 5125:1 5126:1 5127:1 5128:1 5129:1 5130:1  |EV| 
-4.8783639208238582796184346079826e-05  |BT| (NP (NP (NP (NN (Role)))(NP (VBN (phosphorylated))(NN (histone))(NN (H3))(NN (serine))(CD (10))(JJ (DEN-induced))(NN (deregulation))(NN (Pol))(CD (III))(NN (gene))(NN (cell))(NN (proliferation))(NN (transformation))))) |ET|  |BS| 15:F01.829.316.616 183:G04.299.233.750 614:G05.360.340.024.340.364.875.667 926:D12.125.154.800 1416:D12.776.660.470  |ES| 9:1 19:1 94:1 299:1 402:1 503:1 1384:1 1519:1 2187:1 2280:1 2281:1 2735:1 4930:1 5145:1 5146:1  |EV| 
-0.015810359656370565062388777732849  |BT| (S (NP (NP (JJ (Antisense))(NNS (oligodeoxynucleotides))(JJ (human))(NN (superoxide))(NN (dismutase))(CD (2)))(CC (and/or))(NP (JJ (ectopic))(NN (bcl-2))(NN (overexpression))))(VP (VBD (avoided))(NP (NP (NNS (polyphenols)))(SBAR (S (NP (JJ (chemoradiotherapy-induced))(JJ (colorectal))(NN (cancer))(NN (elimination)))(VP (VBD (showed))(NP (NP (JJ (mangano-type))(NN (superoxide))(NN (dismutase))(NN (Bcl-2))(JJ (key))(NN (target))(JJ (molecular))(NN (mechanism)))(VP (VBN (activated))(NP (JJ (combined))(NN (application))(NN (t-PTER))(NNP (QUER))))))))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 54:G05.360.340.024.340.375.500.791.150 55:B01.050.150.900.649.801.400.112.400.400 56:D02.455.426.559.389.657.715 57:D13.695.578.424.450 58:D08.811.682.881 59:E02.186.079  |ES| 17:1 18:1 19:1 36:1 132:1 144:1 145:1 146:1 147:1 148:1 149:1 150:1 151:1 152:1 153:1 154:1 155:1 156:1 157:1 158:1 159:1 160:1 161:1 162:1 163:1 164:1 165:1 166:1 167:1  |EV| 
-0.00088959293472612444020342081785202  |BT| (NP (NP (JJ (Formalin-fixed))(, (,))(NP (NP (NP (NN (paraffin))(JJ (wax-embedded))(JJ (pre-operative))(NN (biopsy)))(PRN (-LRB- (-LRB-))(S (NP (NN (n)))(VP (JJ (=))(NP (CD (14)))))(-RRB- (-RRB-))))(NP (NP (NP (JJ (surgical))(NN (resection))(NN (specimen)))(PRN (-LRB- (-LRB-))(S (NP (NN (n)))(VP (JJ (=))(NP (CD (40)))))(-RRB- (-RRB-))))(NP (S (NP (NP (NN (patient))(JJ (rectal))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (JJ (clinical))(NN (UICC))(NN (stage))(NN (II/III)))(-RRB- (-RRB-))))(VP (VBG (receiving))(NP (NP (JJ (neo-adjuvant))(JJ (5-FU-based))(NN (chemoradiotherapy)))(VP (VBN (studied))(S (NP (NN (TS))(: (-))))))))(, (,))(NP (ADJP (NN (TP))(: (-))(, (,))(ADJP (JJ (DPD-gene))))(NN (expression))(JJ (quantitative))(NNP (TaqMan))(JJ (real-time))(NN (PCR))(NN (laser))(NN (microdissection)))))))) |ET|  |BS| 6:G05.360.340.024.340 50:M01.643 115:E04 154:Z01.058.266.887 257:E05.393.620.500.706 333:D01.045 346:E05.393.620.500.706 347:D02.047.407 559:E01.370.225.500.384.100 560:D03.383.742.698.875.404 561:E02.186.079.500 1341:E01.370.225.998.221.580.500 1342:Z01.639.040 1343:D02.455.612  |ES| 2:1 10:1 14:1 19:1 84:1 115:1 120:1 128:1 304:1 341:1 401:1 548:1 580:1 581:1 582:1 817:1 874:1 875:1 1129:1 1154:1 1440:1 1550:1 1984:1 1986:1 1987:1 1988:1 1989:1 3543:1 4046:1 4782:1 4783:1 4784:1 4785:1 4786:1 4787:1 4788:1 4789:1 4790:1  |EV| 
-0.00026338644603640659624943509697914  |BT| (S (NP (NN (Niclosamide)))(VP (VBD (caused))(NP (NP (NN (dose)))(: (-))(NP (NP (NP (JJ (time-dependent))(NN (reduction))(NN (beta-catenin))(JJ (key))(NN (component)))(PRN (-LRB- (-LSB-))(PP (FW (e.g.))(, (,))(NP (NP (NNS (DVLs)))(, (,))(NP (NP (NN (phospho-GSK3beta)))(PRN (-LRB- (-LRB-))(NP (NN (S9)))(-RRB- (-RRB-))))(, (,))(NP (NN (c-Myc))(NN (Cyclin))(NN (D1)))))(-RRB- (-RSB-))))(JJ (canonical))(NN (Wnt/beta-catenin))(NN (pathway)))))) |ET|  |BS| 23:D12.776.091.249 105:G02.149.115.800.925 215:D12.644.360.262.150.100 322:G01.910 1391:D02.065.199.860.470  |ES| 2:1 10:1 14:1 19:1 60:1 159:1 302:1 370:1 383:1 744:1 824:1 1021:1 1373:1 1378:1 1997:1 2506:1 3236:1 4742:1 5048:1 5049:1 5050:1 5051:1 5052:1 5053:1  |EV| 
-0.17984970949146372731775045394897  |BT| (S (ADVP (RB (Finally)))(, (,))(NP (NN (RNAseq))(NN (analysis)))(VP (VBD (indicated))(SBAR (S (NP (NP (NN (p53))(NN (signaling))(NN (Lgr5)))(CC (+))(NP (NN (stem))(NN (cell))(NN (mouse))))(VP (VBN (exposed))(NP (NNP (AOM)))(ADVP (RB (uniquely)))(VP (VBD (upregulated))(PP (VBG (following))(NP (JJ (n-3))(NN (PUFA))(CC (+))(NN (curcumin))(NN (cotreatment)))))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 11:B01.050.150.900.649.865.635.505.500 69:G02.111.087.800 132:D02.172.080 308:A11.872 618:E02.186 692:D02.455.326.146.485.222.222 1308:D10.212.302.380.410  |ES| 2:1 12:1 19:1 52:1 94:1 125:1 195:1 661:1 1106:1 1541:1 1929:1 1994:1 2652:1 3102:1 3510:1 4673:1 5626:1 5627:1 5628:1 5629:1  |EV| 
-0.10286264534272504533873870968819  |BT| (S (NP (NN (NO-ASA)))(VP (VBD (reduced))(NP (NP (NN (expression))(NN (cyclin))(NN (D1)))(, (,))(NP (NP (JJ (downstream))(NN (target))(NN (gene))(NN (play))(JJ (important))(NN (role)))(NN (colon))(NN (carcinogenesis)))))) |ET|  |BS| 6:G05.360.340.024.340 12:Z01.542.049 15:F01.829.316.616 33:C04.697.098 46:A03.556.124.526.356 79:I03.450.642.693 215:D12.644.360.262.150.100  |ES| 2:1 9:1 19:1 31:1 113:1 115:1 160:1 207:1 238:1 452:1 560:1 743:1 744:1 902:1 3892:1  |EV| 
-0.00033567308992132893763482570648193  |BT| (S (PP (IN (In))(NP (NN (summary))))(, (,))(NP (JJ (small))(NN (molecule))(NN (inhibitor))(NN (imatinib)))(VP (VP (VBZ (attenuates))(NP (JJ (stromal))(NN (cell))(NN (proliferation))(JJ (PDGF-C-induced))(NN (HCC))))(, (,))(VP (VBZ (coincides))(NP (NP (VBN (decreased))(NN (expression))(NN (CD34))(NN (PDGFRalpha)))(, (,))(NP (VBN (activated))(NN (Akt))))))) |ET|  |BS| 104:C04.557.470.200.025.255 183:G04.299.233.750 378:D08.811.913.696.620.682.700.755 1370:D08.811.913.696.620.682.725.400.900.500  |ES| 2:1 19:1 94:1 115:1 163:1 180:1 202:1 244:1 299:1 380:1 441:1 490:1 750:1 1289:1 2423:1 4916:1 4917:1 4918:1 4919:1 4920:1 4921:1  |EV| 
-0.0027240208133605392504250630736351  |BT| (S (PP (IN (In))(NP (NN (addition))))(, (,))(NP (JJ (ursolic))(NN (acid)))(VP (VBD (suppressed))(NP (ADJP (NP (NP (NN (EGF))(NN (receptor)))(PRN (-LRB- (-LRB-))(NP (NN (EGFR)))(-RRB- (-RRB-))))(VBD (induced)))(NN (p53))(NN (p21))(NN (expression))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 64:D08.811.913.696.620.682.725.400.009.300  |ES| 2:1 10:1 12:1 14:1 19:1 115:1 186:1 187:1 244:1 307:1 412:1 468:1 1135:1 1275:1 4890:1 4891:1  |EV| 
